<SEC-DOCUMENT>0001213900-25-101720.txt : 20251023
<SEC-HEADER>0001213900-25-101720.hdr.sgml : 20251023
<ACCEPTANCE-DATETIME>20251023164608
ACCESSION NUMBER:		0001213900-25-101720
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20251023
DATE AS OF CHANGE:		20251023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Capstone Holding Corp.
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291041
		FILM NUMBER:		251413613

	BUSINESS ADDRESS:	
		STREET 1:		5141 W. 122ND STREET
		CITY:			ALSIP
		STATE:			IL
		ZIP:			60803
		BUSINESS PHONE:		7083710660

	MAIL ADDRESS:	
		STREET 1:		5141 W. 122ND STREET
		CITY:			ALSIP
		STATE:			IL
		ZIP:			60803

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Capstone Therapeutics Corp.
		DATE OF NAME CHANGE:	20100521

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOLOGIC CORP
		DATE OF NAME CHANGE:	19940211
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea0262082-s1_capstone.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As&nbsp;filed&nbsp;with&nbsp;the&nbsp;Securities&nbsp;and&nbsp;Exchange&nbsp;Commission&nbsp;on&nbsp;October
23, 2025.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B>&nbsp;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-1<BR>
REGISTRATION STATEMENT<BR>
Under The Securities Act&nbsp;of&nbsp;1933</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CAPSTONE HOLDING CORP.</U><BR>
(Exact name of Registrant as specified in its charter)</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5090</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>86-0585310</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State or Other Jurisdiction of <BR>
Incorporation or Organization)</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary Standard Industrial <BR>
Classification Code Number)</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.&nbsp;Employer <BR>
Identification Number)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5141 W. 122<SUP>nd</SUP> Street<BR>
Alsip, IL&nbsp;60803<BR>
(708)&nbsp;371-0660<BR>
(Address,&nbsp;including&nbsp;zip&nbsp;code,&nbsp;and&nbsp;telephone&nbsp;number,&nbsp;including&nbsp;area&nbsp;code,&nbsp;of&nbsp;Registrant&rsquo;s&nbsp;principal&nbsp;executive&nbsp;offices)</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Matthew Lipman, Chief Executive Officer<BR>
Edward Schultz, Chief Financial Officer<BR>
Capstone Holding Corp.<BR>
5141 W. 122<SUP>nd</SUP> Street<BR>
Alsip, IL&nbsp;60803<BR>
<U>(708)&nbsp;371-0660<BR>
</U>(Name, address, including zip code, and telephone number&nbsp;including area code, of agent for service)</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">With Copies to:</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Joseph M.&nbsp;Lucosky, Esq.<BR>
Lawrence Metelitsa, Esq.<BR>
Steven A. Lipstein, Esq.<BR>
Lucosky Brookman LLP<BR>
101 Wood Avenue South, 5<SUP>th</SUP> Floor<BR>
Woodbridge, New Jersey 08830<BR>
Phone: (732)&nbsp;395-4400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fax: (732) 395-4401</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B> As soon as practicable after the effective date of this Registration Statement.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act&nbsp;of&nbsp;1933, check the
following box.&nbsp;&#9746;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register <B>additional</B>
securities for an offering pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule&nbsp;462(c)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule&nbsp;462(d)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;&#9744;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule&nbsp;12b-2 of the Exchange&nbsp;Act.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large-Accelerated Filer</FONT></TD>
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer</FONT></TD>
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Accelerated Filer</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller Reporting Company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act.&nbsp;&#9744;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This registration statement shall hereafter become effective in
accordance with the provisions of section 8(a) of the Securities Act of 1933.</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>The information in
this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PRELIMINARY PROSPECTUS</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%"><FONT STYLE="color: Red">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
    TO COMPLETION</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%"><FONT STYLE="color: Red">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>DATED:
    OCTOBER 23, 2025</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CAPSTONE HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4,306,664 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the offer and
resale from time to time by the selling stockholder identified in this prospectus of up to an aggregate of 4,306,664 shares of
common stock, par value $0.0005 per share (the &ldquo;Common Stock&rdquo;), of Capstone Holding Corp., a Delaware corporation (the
&ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;), consisting of 4,306,664 shares issuable upon
conversion of the convertible note, in the principal amount of $3,545,712.42 issued pursuant to the securities purchase agreement,
dated July 29, 2025 (the &ldquo;Purchase Agreement&rdquo;). The number of shares issuable upon conversion of the convertible note is
based on a fixed conversion price of $1.10 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our registration of the shares of Common Stock
covered by this prospectus does not mean that the selling stockholder will offer or sell any of the shares. The selling stockholder may
offer and sell or otherwise dispose of the shares of Common Stock described in this prospectus from time to time through public or private
transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. See &ldquo;<I>Plan
of Distribution</I>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not selling any shares of Common Stock
offered by this prospectus and will not receive any of the proceeds from the sale by the selling stockholder of the shares of Common Stock
offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder will pay all underwriting
discounts and selling commissions, if any, in connection with the sale of the shares of Common Stock. We have agreed to pay certain expenses
in connection with this registration statement and to indemnify the selling stockholder and certain related persons against certain liabilities.
No underwriter or other person has been engaged to facilitate the sale of shares of Common Stock in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder is an &ldquo;underwriter&rdquo;
within the meaning of Section 2(a)(11) of the Securities Act and any profits on the sales of shares of our Common Stock by the selling
stockholder and any discounts, commissions, or concessions received by the selling stockholder are deemed to be underwriting discounts
and commissions under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of our Common Stock are listed on the Nasdaq Capital Market
(&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;CAPS&rdquo;. On October 22, 2025, the closing sale price of our Common Stock was $1.14
per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &ldquo;controlled company&rdquo; following
this offering as defined under the Nasdaq Stock Market Rules. We are a &ldquo;controlled company&rdquo; because entities individually
or jointly controlled by Matthew Lipman, our chief executive officer and a member of our board of directors, and Michael Toporek, the
chairman of our board of directors (Brookstone Partners Acquisition XIV, LLC (&ldquo;BPA XIV, LLC&rdquo;), BP Peptides LLC, and Nectarine
Management LLC) have the ability to control all matters requiring shareholder approval because these entities own over 50% of our Common
Stock and control over 50% of our voting stock (inclusive of the votes of the over 50% of the Series B Preferred Stock shares outstanding).
Although we are considered a &ldquo;controlled company&rdquo;, we do not intend to rely on the exemptions to corporate governance requirements
as a &ldquo;controlled company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company&rdquo;
and a &ldquo;smaller reporting company,&rdquo; as defined in Rule&nbsp;12b-2 of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as
amended, and have elected to take advantage of certain scaled disclosure available to smaller reporting companies. This prospectus is
intended to comply with the requirements that apply to an issuer that is a smaller reporting company. See &ldquo;<I>Prospectus Summary</I>&nbsp;<I>&mdash;&nbsp;Implications
of Being an Emerging Growth Company and a Smaller Reporting Company</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a high
degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 8 of this prospectus and under similar headings in the other documents
that are incorporated by reference into this prospectus for a discussion of information that should be considered in connection with an
investment in our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on the information contained
in this prospectus, contained in the other documents that are incorporated by reference into this prospectus, or contained any prospectus
supplement or amendment hereto. We have not authorized anyone to provide you with different information.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities offered hereby, or determined if this prospectus is
truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is _________ , 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 91%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">Cautionary Note Regarding Forward-Looking Statements</A></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination of Offering Price</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Convertible Note Financing</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Stockholder</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation of Certain Information by Reference</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find More Information</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on information contained
in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We have not, and the selling
stockholder has not, authorized anyone to provide you with additional information or information different from that contained in this
prospectus or in any free writing prospectus. Neither the delivery of this prospectus nor the sale of our securities means that the information
contained in this prospectus or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus.
This prospectus is not an offer to sell or the solicitation of an offer to buy our securities under any circumstances in which the offer
or solicitation is unlawful or in any state or other jurisdiction where the offer is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The information in this prospectus is accurate
only as of the date on the front cover of this prospectus and the information in any free writing prospectus that we may provide you in
connection with this offering is accurate only as of the date of that free writing prospectus. Our business, financial condition, results
of operations and prospects may have changed since those dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>No person is authorized in connection with
this prospectus to give any information or to make any representations about us, the securities offered hereby or any matter discussed
in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation
is given or made, such information or representation may not be relied upon as having been authorized by us.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither we nor the selling stockholder have
done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that
purpose is required, other than the United&nbsp;States. You are required to inform yourself about, and to observe any restrictions relating
to, this offering and the distribution of this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights selected information
appearing elsewhere in this prospectus. While this summary highlights what we consider to be important information about us, you should
carefully read this entire prospectus and the documents incorporated by reference in this prospectus before investing in our Common Stock,
especially the risks and other information we discuss under the heading &ldquo;Risk Factors&rdquo; and our consolidated financial statements
and related notes incorporated by reference herein. Our fiscal year end is December&nbsp;31, and our fiscal&nbsp;years ended December&nbsp;31,
2024 and 2023 are sometimes referred to herein as fiscal&nbsp;years 2024 and 2023, respectively. Some of the statements made in this prospectus
discuss future events and developments, including our future strategy and our ability to generate revenue, income and cash flow. These
forward-looking statements involve risks and uncertainties which could cause actual results to differ materially from those contemplated
in these forward-looking statements. See &ldquo;Cautionary Note&nbsp;Regarding Forward-Looking Statements&rdquo;. Unless otherwise indicated
or the context requires otherwise, the words &ldquo;Capstone,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;, the &ldquo;Company&rdquo;
or &ldquo;our Company&rdquo; refer to Capstone Holding Corp., a Delaware corporation, and its subsidiaries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capstone Holding Corp. is a building products
distribution network. The existing company is comprised of Instone, a leading distributor of thin veneer stone and related masonry products
in the United States, serving both residential and commercial construction markets. Founded over 30 years ago, we have grown to become
the largest wholesale distributor in the thin veneer masonry products industry. Our comprehensive product offering includes a wide range
of manufactured and natural stone products, supported by a strategically located distribution network designed to provide reliable and
efficient service to our diverse customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are committed to being the preferred partner
for our customers by providing high-quality products, expert support, and exceptional service. Our success is driven by our deep industry
expertise, long-standing customer relationships, and a relentless focus on operational excellence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate History</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was formed in 1987 as OrthoLogic Corp.
In 2005, the Company filed its restated certificate of incorporation (the &ldquo;Restated Certificate of Incorporation&rdquo;). In 2010,
the Company changed its name to Capstone Therapeutics Corp. On August 22, 2019, the Company filed a certificate of amendment to its Restated
Certificate of Incorporation effecting a 1 for 1,000 reverse stock split of the Common Stock of the Company, whereby each 1,000 shares
of Common Stock of the Company became 1 share of Common Stock. In 2021, the Company filed a certificate of amendment to its Restated Certificate
of Incorporation decreasing the total number of shares of Common Stock authorized to be issued by the Company from 150,000,000 shares
to 205,000 shares, consisting of 200,000 shares of Common Stock, par value $0.0005 per share and 5,000 shares of preferred stock, par
value $0.0005 per share. On February 18, 2022, the Company filed a certificate of amendment to its Restated Certificate of Incorporation,
changing the Company&rsquo;s name from Capstone Therapeutics Corp. to Capstone Holding Corp. On February 20, 2025, following the Company&rsquo;s
controlling shareholder&rsquo;s approval, the Company filed an amendment to its Restated Certificate of Incorporation with the Secretary
of State of the State of Delaware to increase the authorized shares of Common Stock to 50,000,000 shares and increase the authorized shares
of preferred stock to 25,000,000 shares. On February 20, 2025, the Company filed a Certificate of Designation (the &ldquo;Series B Certificate
of Designation&rdquo;) with the Delaware Secretary of State which designated 2 million shares of the Company&rsquo;s authorized preferred
stock as Series B Preferred Stock (&ldquo;Series B Preferred Stock&rdquo;), no par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

</DIV>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Business Strategy and Operating Model</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Capstone</B>&nbsp;<B>Long-Term</B>&nbsp;<B>Growth
Strategy.&nbsp;</B>Our long-term growth strategy is built on the foundational strengths of our current operating subsidiary and the strategic
opportunities available in the building products distribution and manufacturing industry. Our strategy has the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Deep Team</B>.&nbsp;Capstone is
controlled by Brookstone Partners, a private equity group with 25 years of deep expertise in building products investment. Brookstone
Partners is controlled by Matthew Lipman, our chief executive officer and a member of our board of directors, and Michael Toporek, the
chairman of our board. The Capstone leadership team includes seasoned operating executives and building products acquisition and investment
professionals. Capstone&rsquo;s leadership team includes its Lead Independent Director, Charles &ldquo;Chuck&rdquo; Dana. Mr. Dana spent
19 years at Owens Corning, a leading building materials company. At Owens Corning, Mr. Dana held various positions including Controller,
President Global Composites and then Group President Building Materials. In addition, from the Company&rsquo;s acquisition of Instone
in April 2020 through December 31, 2024, Instone&rsquo;s revenues have increased from approximately $32.2 million to approximately $44.9
million. In February 2008, a Brookstone Partners affiliate invested $8.8 million in Woodcrafter&rsquo;s Home Products Holdings LLC. Brookstone&rsquo;s
team worked with Woodcrafter&rsquo;s management to grow earnings and Brookstone completed the sale of all of its interests in Woodcrafter&rsquo;s
for $32 million in December 2013. The ability to identify, acquire and integrate acquisition candidates is a critical skill set to augment
the operating expertise that drives organic growth. The current operating company has successfully executed multiple acquisitions and
integrations, laying a solid foundation for continued expansion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Strategic Timing.&nbsp;</B>We believe
we are strategically positioned to capitalize on market conditions within the building products sector. Historically, acquiring companies
at interest rate peaks has yielded strong returns, and we are poised to leverage these strategic investment opportunities as the market
evolves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Industry Dynamics.</B>&nbsp;According
to the Bain &amp; Company Global M&amp;A Report published in 2024 (the &ldquo;Bain Report&rdquo;), this is &ldquo;just the type of environment
that has proved to offer opportunities to companies that are willing to make bold moves.&rdquo; The Bain Report goes on to say, &ldquo;building
products companies that make frequent and material acquisitions substantially outpace inactive companies in total shareholder returns,
9.6% vs 2.7%&rdquo; and &ldquo;the most successful companies will pursue scope M&amp;A to build product, geography, and capability adjacencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The M&amp;A environment for the building
products sector is expected to improve because, according to the Bain Report, &ldquo;there are ample one-off opportunities to acquire
struggling assets&rdquo;, and &ldquo;financial investors have taken a step back, especially in North America, removing a potentially formidable
layer of competition.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><U>Scale.</U>&nbsp;For scale M&amp;A,
opportunities in core businesses allow for more operational synergies. The Bain Report states that &ldquo;allowing management to focus
on a more related group of products with some level of shared channels, end markets, or manufacturing processes helps focus efforts and
tells a clearer equity story.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><U>Scope.</U>&nbsp;Given macroeconomic
uncertainty, companies who leverage their parenting advantage, the ability to effectively manage and integrate acquisitions, will be the
most successful with regards to scope M&amp;A. The Bain Report states that &ldquo;the path to leadership generally means overlooking smaller
assets in favor of bigger players for a first move in a new space.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_001.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The &ldquo;Annual total shareholder
returns for building products companies&rdquo; chart and quotes from the Bain Report are used with permission from Bain &amp; Company.
The Bain Report was not commissioned by the Company. The Company does not currently and has not in the past had a direct or indirect
business relationship with Bain &amp; Company. The Bain Report is publicly available via the Insight - Featured Topics portion of Bain
&amp; Company&rsquo;s website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Strategic Positioning.</B>&nbsp;We
believe we are strategically well-positioned to take advantage of the current market opportunities because of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><U>Team strength.</U>&nbsp;The industry
experience of the Board and Instone management provides the Company with the expertise to evaluate, acquire, and integrate acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><U>Experience integrating acquisitions.</U>&nbsp;Since
2006, the Company has successfully integrated four acquisitions. The team believes the Company has the resources and expertise to continue
to integrate acquisitions successfully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><U>Geographic distribution footprint
of Instone.</U>&nbsp;The current service area of the Company, which includes 31 states (with such states having over 60% of American households),
provides a good basis on which to make both &ldquo;scale&rdquo; and &ldquo;scope&rdquo; acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Growth Premium.&nbsp;</B>As Capstone
continues to scale, growing its EBITDA, we anticipate benefiting from valuation premiums associated with increased size. This growth,
coupled with consistent earnings performance, is expected to drive substantial shareholder value and enhance our market positioning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our current operating company, Instone,
intends to drive sustainable growth, expands its geographic presence in the building products industry, and delivers superior value to
its customers, shareholders, and other stakeholders.</I></B>&nbsp;We expect to work with Instone to achieve this through the following
strategic pillars:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Expand Market Presence.&nbsp;</B>We
are committed to expanding our geographic footprint, increasing penetration in existing markets, and entering new, underserved regions.
Our sales and marketing team continues to seek new opportunities to onboard customers in markets we are not currently servicing. In 2024,
we onboarded customers in 6 new states, which are included in our distribution network of 31 states. We will achieve this through both
organic growth and strategic acquisitions that complement our existing business and provide opportunities to broaden our product offerings
and customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Enhance Product Portfolio.&nbsp;</B>We
continuously strive to expand and diversify our product offerings to meet the evolving needs of our customers. This includes introducing
new textures, colors, and materials within our stone product lines, as well as expanding into adjacent building products and stone substitutes.
By broadening our portfolio, we aim to increase our share of wallet with existing customers and attract new customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Operational Excellence.&nbsp;</B>We
are focused on optimizing our operations to improve efficiency, reduce costs, and enhance customer satisfaction. This involves investing
in advanced technologies, streamlining our supply chain, and implementing best practices across all aspects of our business. Operational
excellence is key to maintaining our competitive edge and ensuring long-term profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Customer-Centric</B>&nbsp;<B>Approach.&nbsp;</B>Our
customers are at the heart of everything we do. We are committed to building strong, long-lasting relationships by providing high-quality
products, exceptional service, and expert support. Our goal is to be the preferred partner for our customers, helping them succeed in
their projects and achieve their business objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>Innovation.&nbsp;</B>We recognize
the importance of innovation in the building products sector and prioritize it, continually seeking new ways to improve our products,
processes, and services to stay ahead of industry trends and meet the demands of a changing market. The most recent example is our introduction
of the Toro<SUP>&reg;</SUP>&nbsp;family of manufactured stone products. We used our 30 years of market knowledge to formulate a product
offering that is well thought out to meet the needs of end use customers and distributors. We painstakingly designed each color family.
We honed in on key manufacturing steps to drive quality and consistency then thoughtfully designed packaging to meet the needs of distributors.
The end result was a set of products that competes with high-end alternatives in the sector on aesthetics, but for a better value. We
expect Toro<SUP>&reg;</SUP>&nbsp;to help drive significant organic revenue growth in the next three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Public Offering and Uplisting on Nasdaq Capital Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 7, 2025, the Company closed its follow-on public offering
(the &ldquo;Public Offering&rdquo;) of 1,250,000 shares of Common Stock. On March 6, 2025, the Company&rsquo;s Common Stock began trading
on the Nasdaq Capital Market under the symbol &ldquo;CAPS&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

</DIV>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brookstone Investment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in an 8-K filing with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on July&nbsp;17, 2017 (filed under the issuer name of Capstone Therapeutics Corp.), on
July&nbsp;14, 2017, the Company entered into a Securities Purchase, Loan and Security Agreement (the &ldquo;Brookstone Agreement&rdquo;)
with BP Peptides, LLC (&ldquo;Brookstone&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Brookstone Agreement, Brookstone
funded an aggregate of $3,440,000, with net proceeds of approximately $2,074,000, after paying off (a)&nbsp;certain convertible promissory
notes dated December&nbsp;11, 2015 and due July&nbsp;14, 2017, payable to Biotechnology Value Fund, L.P. and affiliated entities and (b)&nbsp;transaction
costs. Of this amount, $1,012,500 went towards the purchase of 18,000 (following a 1 for 750 reduction in the authorized Common Stock
in February&nbsp;2021) newly issued shares of our Common Stock, and $2,427,500 was in the form of a secured loan, due October&nbsp;15,
2020. On July&nbsp;14, 2017 Brookstone also purchased 6,722 (following a 1 for 750 reduction in the authorized Common Stock in February&nbsp;2021)
shares of the Company&rsquo;s Common Stock directly from Biotechnology Value Fund affiliated entities, resulting in ownership of 24,722&nbsp;shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August&nbsp;2019 the Company filed a Form&nbsp;15
and received approval from its shareholders for a 1-for-750 reverse stock split of common shares to reduce the number of authorized common
shares to 200,000 and a 1 for 400 reverse stock split of the preferred shares to reduce the number of preferred shares to 2,500. This
split brought shareholders of record to below 300 and allowed Capstone to become exempt from standard reporting requirements of the SEC.&nbsp;The
Company continues to fully comply with the Alternate Reporting Format guidelines of the OTCQB, which, in part, requires filing of quarterly
financial statements and audited annual financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Building Materials Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone, LLC is the Company&rsquo;s primary
operating subsidiary, engaged in distributing masonry stone products for residential and commercial construction across the Midwest and
Northeast U.S, under the trade names Instone and Northeast Masonry Distributors (NMD), which has been the Company&rsquo;s primary business
activity since 2020. The Company acquired a controlling interest in TotalStone on April 1, 2020, and, upon completion of the public offering
on March 7, 2025, now owns 100% of its equity interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone, LLC (<I>dba</I> &ldquo;Instone&rdquo;),
a Delaware limited liability company, was formed on October&nbsp;4, 2006. TotalStone is engaged in the distribution of pre-cast specialty
items and thin stone products and related accessories. All of its operations are performed in Illinois, Ohio and New Jersey. Its administrative
functions are performed in Massachusetts and Illinois, with its corporate headquarters located in New Jersey. TotalStone services the
Northeast and Midwest regions, which comprise 31 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone has a wholly owned subsidiary that
is a single member Delaware limited liability company, Northeast Masonry Distributors, LLC (&ldquo;NMD&rdquo;, f/k/a NEM Purchaser, LLC),
that was formed on September&nbsp;23, 2019. On November&nbsp;14, 2019, NEM Purchaser, LLC completed the purchase of Northeast Masonry
Distributors, LLC including all of the assets and assumed liabilities, receivables, fixed assets, and other assets. The aggregate purchase
price was $6,029,342. Post acquisition, NEM Purchaser LLC changed its name to Northeast Masonry Distributors, LLC. Prior to the acquisition,
NMD was engaged in light fabrication and distribution of natural stone products with operations in Plainville, Massachusetts. All of its
manufacturing and distribution operations are performed in Massachusetts. Administrative functions are performed in Massachusetts and
New Jersey. NMD services the Northeast and Midwest regions, which comprise 31 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone operated under a management agreement
with the Company for strategic and financial advisory services. On March 7, 2025, a restructuring was completed, under which all of TotalStone&rsquo;s
outstanding Class B and Class C membership interests were exchanged for 3,782,641 shares of the Company&rsquo;s Common Stock. Following
this exchange, the Company became the sole member of TotalStone. Effective April 1, 2025, the management agreement between TotalStone
and the Company was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In connection with the restructuring, certain TotalStone management
warrants were cancelled, and TotalStone&rsquo;s special preferred interests were exchanged for debt obligations under the Company&rsquo;s
credit agreement with Stream Finance, LLC. TotalStone continues to maintain a revolving credit facility with Berkshire Bank, which provides
for up to $14 million in working capital financing.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Acquisition of Carolina Stone Holdings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 15, 2025, the Company entered
into a membership interest purchase agreement (the &ldquo;D22L Purchase Agreement&rdquo;) with D22L, Inc., a North Carolina corporation
(the &ldquo;Seller Entity&rdquo;), David Clary, and Stuart Powell (together with David Clary and the Seller Entity, the &ldquo;Seller&rdquo;),
to purchase from the Seller Entity all of the issued and outstanding membership interests (the &ldquo;Holdings Membership Interests&rdquo;)
in Carolina Stone Holdings, LLC, a Delaware limited liability company (&ldquo;Carolina Stone Holdings&rdquo;), which owns all of the issued
and outstanding membership interests of Carolina Stone Distributors, LLC, a Delaware limited liability company (together with the Carolina
Stone Holdings, the &ldquo;Carolina Stone Companies&rdquo;). The aggregate purchase price for the Holding Membership Interests is (i)
$2,625,000 in cash, subject to adjustment set forth in Section 2.6 of the D22L Purchase Agreement, plus (ii) a seller note in the original
principal amount of $1,250,000, plus (iii) the amount payable pursuant to the terms of the earn-out agreement (the &ldquo;Acquisition&rdquo;).
The Carolina Stone Companies operate showrooms, warehouses and staging yards to sell and distribute stone products and the installation
of stonework in residential and commercial properties. The Acquisition closed on August 22, 2025.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Notes Exchange and Creation of Series Z 8%
Non-Convertible Preferred Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 30, 2025, the Company entered into
an exchange agreement with BP Peptides, LLC and Brookstone Partners Acquisition XXI Corporation (together, the &ldquo;Brookstone entities&rdquo;),
entities controlled by Matthew Lipman, the Chief Executive Officer of the Company and Michael Toporek, the Chairman of the board of directors.
Pursuant to the Exchange Agreement, the Brookstone entities exchanged notes with an aggregate principal and interest amount of approximately
$1.94 million for 642,276 and 825,067 shares, respectively, of the Company&rsquo;s newly created Series Z 8% Non-Convertible Preferred
Stock. The exchange was based on the Nasdaq Official Closing Price of the Company&rsquo;s Common Stock of $1.32 per share on the day prior
to the transaction.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 30, 2025, following Board approval,
the Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series Z 8% Non-Convertible Preferred Stock
(the &ldquo;Certificate of Designation&rdquo;) with the Secretary of State of the State of Delaware with up to three million five hundred
thousand (3,500,000) Series Z Preferred shares being authorized for issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Certificate of Designation, the
Series Z Preferred shares are not convertible into shares of Common Stock, has voting rights of one vote per shares and will vote together
as a single class with the Common Stock shareholders. Each share of Series Z Preferred will accrue cumulative dividends at a rate of eight
percent (8%) per annum based on the $1.32 stated value per share of the Series Z Preferred, accruing daily and payable, at the sole option
of the Board, either in cash or payment-in-kind via the issuance of further shares of Series Z Preferred. The Series Z Preferred shares
are redeemable upon the earlier of the seven year anniversary of the issuance of the shares or the occurrence of a fundamental transaction
(as defined in the Certificate of Designation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Corporate Actions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2020, the Company and Brookstone
amended the Brookstone Agreement to extend the Secured Debt&rsquo;s maturity to March&nbsp;31, 2022 and continued deferral of interest
payable. As consideration, the Company has provided an option, for a period ending December&nbsp;31, 2021, to convert all or part of the
aggregate outstanding principal amount and any accrued interest of the Secured Debt or exercise of any warrant into Capstone Common Stock
at a conversion price range of between $10.00 and $30.00 per share, as determined by an independent valuation at the time of conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December&nbsp;2020, Brookstone exercised its
option to convert $572,700 of accrued interest and secured debt into 24,900&nbsp;shares of Capstone Common Stock at an exercise price
of $23 per share as supported by independent valuation. With this acquisition, Brookstone owned 54.8% of the Company&rsquo;s outstanding
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2021, the Company and Brookstone
amended the Brookstone Agreement to extend the Secured Debt&rsquo;s maturity to April&nbsp;1, 2024 (subsequently extended to December&nbsp;31,
2024) with continued interest deferral on the loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February&nbsp;2022, the Company legally changed
its name from Capstone Therapeutics Corp. to Capstone Holding Corp. reflecting its primary line of business in building products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2022, Brookstone exercised its option
to convert $688,104 of accrued interest and $1,951,260 of secured debt into 78,153&nbsp;shares of Capstone Common Stock at an exercise
price of $24.75 per share as supported by independent valuation. With this acquisition, Brookstone currently owns 77.3% of the Company&rsquo;s
outstanding Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, Capstone and Brookstone Acquisition
Partners XXI, LLC (&ldquo;Brookstone XXI&rdquo;), a related entity to the Company&rsquo;s majority shareholder, agreed to terms of an
unsecured promissory note in the amount of $800,000 as part of a 2021 transaction through its Capstone Beta, LLC (&ldquo;Beta&rdquo;)
subsidiary to own a minority membership interest in Diamond Products Holdings, LLC (&ldquo;DPH&rdquo;) valued at $8&nbsp;million for a
$8&nbsp;million secured note payable to Brookstone Acquisition Partners XXI. The agreed to terms of the $800,000 note were formalized
in a note agreement executed on March&nbsp;31, 2024. The sole assets of DPH consisted of a 95% membership interest in Diamond Products
LLC (&ldquo;Diamond&rdquo;), a consumer products holding company. The majority membership interests in DPH and Diamond were controlled
by Brookstone XXI. The $800,000 unsecured promissory note was triggered when the members of Diamond sold their membership interests to
a third party as part of a restructuring and recapitalization transaction of the Diamond operating entities. This $800,000 unsecured promissory
note was issued on March&nbsp;31, 2024. The primary consideration received in the transaction was the release of guarantees of the senior
debt of Diamond operating entities. No cash proceeds were received in the transaction. Pursuant to the terms of the Beta and Brookstone
XXI $8&nbsp;million secured note, upon sale or disposition of the membership interests in Diamond, Brookstone XXI&rsquo;s remaining payments
due under the note are limited to cash proceeds received by DPH from the sale, accrued interest and a limited payment guaranty of $800,000
provided by Capstone. Since no cash proceeds were received upon the sale of the Diamond membership interests, the $8&nbsp;million note
payable to Brookstone XXI was forgiven and replaced by the new $800,000 note issued by Capstone resulting in a net $7.2&nbsp;million gain
on extinguishment of debt which offset the $8&nbsp;million write-off of the investment in DPH. This promissory note of $800,000 plus accrued
interest of $240,555 (as of September&nbsp;30, 2024) has been amended and extended for maturity through June&nbsp;30, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May&nbsp;2024, the Board authorized and declared
a dividend distribution of one right (a &ldquo;Right&rdquo;) for each outstanding share of Common Stock, par value $0.0005 per share,
of the Company to shareholders of record as of the close of business on May&nbsp;1, 2024. Each Right entitles the registered holder to
purchase from the Company one one-hundredth of a share of Series&nbsp;A Preferred Stock, par value $0.0005 per share, of the Company at
an exercise price of $5.00 per one one-hundredth of a Preferred Share, subject to adjustment. The terms of the Rights are set forth in
a Tax Benefit Preservation Plan (the &ldquo;Benefit Plan&rdquo;), dated as of May&nbsp;1, 2024, between the Company and Computershare
Inc., as rights agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By adopting the Benefit Plan, the Board is seeking
to protect the Company&rsquo;s ability to use its net operating losses and other tax attributes (collectively, &ldquo;Tax Benefits&rdquo;).
The Company views its Tax Benefits as highly valuable assets that are likely to inure to the benefit of the Company and its shareholders.
The Board believes that it is in the best interests of the Company and its shareholders that the Company provide for the protection of
these assets. The final expiration date of the Benefit Plan is April&nbsp;1, 2027. The Benefit Plan was cancelled per the Master Exchange
and Other Transaction Agreement executed on March 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&nbsp;11, 2024, BP Peptides, LLC (a
Brookstone entity) and the Company agreed to the terms of the Second Amended and Restated Note, with a principal amount of $700,617.52
and an accrued interest of $101.810.28, at an initial interest rate of 6.0% per annum, to extend the maturity date through June&nbsp;30,
2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Implications of Being an Emerging Growth and
a Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company&rdquo;
as defined in Jumpstart Our Business Startups Act of 2012 (the &ldquo;JOBS Act&rdquo;). As an emerging growth company, we are eligible
to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not
emerging growth companies, including, but not limited to: (1) presenting only two years of audited financial statements in addition to
any required unaudited interim financial statements with correspondingly reduced &ldquo;Management&rsquo;s Discussion and Analysis of
Financial Condition and Results of Operations&rdquo; disclosure in this prospectus; (2) not being required to comply with the auditor
attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &ldquo;Sarbanes-Oxley Act&rdquo;); (3) having reduced disclosure
obligations regarding executive compensation; (4) being exempt from the requirements to hold a non-binding advisory vote on executive
compensation or to seek stockholder approval of any golden parachute payments not previously approved; and (5) not being required to adopt
certain accounting standards applicable to public companies until those standards would otherwise apply to private companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are still evaluating our options under
the JOBS Act, we may take advantage of some or all of the reduced regulatory and reporting obligations that will be available to us so
long as we qualify as an emerging growth company, and thus the level of information we provide may be different than that of other public
companies. If we do take advantage of any of these exemptions, some investors may find our securities less attractive, which could result
in a less active trading market for our Common Stock, and the price of our Common Stock may be more volatile. As an emerging growth company
under the JOBS Act, we are permitted to delay the adoption of new or revised accounting pronouncements applicable to public companies
until such pronouncements are made applicable to private companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not intend to take advantage of this extended
transition period, which means that the financial statements included in this prospectus, as well as any financial statements that we
file in the future, will be subject to all new or revised accounting standards generally applicable to public companies. The decision
not to take advantage of the extended transition period is irrevocable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We could remain an emerging growth company until
the earliest to occur of: (1) the end of the fiscal year following the fifth anniversary of this offering; (2) the first fiscal year after
our annual gross revenues are $1.235&nbsp;billion or more; (3) the date on which we have, during the previous three-year period, issued
more than $1.0&nbsp;billion in non-convertible debt securities; or (4) the date on which we are deemed to be a &ldquo;large accelerated
filer&rdquo; under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). We have taken advantage of reduced
disclosure regarding executive compensation arrangements and the presentation of certain historical financial information in this prospectus,
and we may choose to take advantage of some but not all of these reduced disclosure obligations in future filings. If we do, the information
that we provide to our stockholders may be different from what you might get from other public companies in which you hold stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also a smaller reporting company, as defined
in the Exchange Act. Even after we no longer qualify as an emerging growth company, we may still qualify as a smaller reporting company,
which would allow us to continue taking advantage of many of the same exemptions from disclosure requirements, including reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements. In addition, for so long as we continue to
qualify as a non-accelerated filer, we will not be required to comply with the auditor attestation requirements of Section 404(b) of the
Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capstone Holding Corp., formerly known as Capstone
Therapeutics Corp. and OrthoLogic Corp., was incorporated in Delaware in 1987 as a domestic corporation, with formal name changes in February&nbsp;2022
and May&nbsp;2010, respectively. The Company&rsquo;s principal executive offices are located at 5141 W. 122<SUP>nd</SUP> St. Alsip, IL&nbsp;60803
and the telephone number is (708)&nbsp;371-0660.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock offered by the selling stockholder</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 69%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 4,306,664 shares of our Common Stock, assuming the issuance of 4,306,664 shares issuable upon the conversion of the senior secured convertible note issued pursuant to the Purchase Agreement. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock outstanding before the offering</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,906,205 shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock to be outstanding after this offering</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,212,869 shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of proceeds</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any of the proceeds from the resale by the selling stockholder of the shares of Common Stock issuable upon conversion of the senior secured convertible note. We may use the proceeds from sales of the Convertible Notes (as defined herein) to the selling stockholder for working capital and general corporate purposes. See section entitled &ldquo;<I>Use of Proceeds</I>&rdquo;.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq Capital Market Trading Symbol </B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Common Stock is listed on the Nasdaq Capital Market under the symbol &ldquo;CAPS&rdquo;.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not anticipate paying dividends on our Common Stock for the foreseeable future.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk factors</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our securities is highly speculative and involves a high degree of risk. You should carefully consider the information set forth in the &ldquo;<I>Risk Factors</I>&rdquo; section beginning on page 8 before deciding to invest in our securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing in our securities involves a great
deal of risk. Careful consideration should be made of the following factors as well as other information included in this prospectus before
deciding to purchase our securities. We have also identified a number of these factors under the heading &ldquo;Risk Factors&rdquo; in
our periodic reports we file with the SEC, including our annual report on Form 10-K for the year ended December 31, 2024 (the &ldquo;Annual
Report&rdquo;), which section is incorporated by reference herein. There are many risks that affect our business and results of operations,
some of which are beyond our control. Our business, financial condition or operating results could be materially harmed by any of these
risks. This could cause the trading price of our securities to decline, and you may lose all or part of your investment. Additional risks
that we do not yet know of or that we currently think are immaterial may also affect our business and results of operations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks related to this offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The issuance of our Common Stock to the
selling stockholder may cause dilution and the sale of the shares of Common Stock acquired by the selling stockholder, or the perception
that such sales may occur, could cause the price of our Common Stock to decrease.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of our Common Stock issuable upon conversions
of the Convertible Note and the sale of such shares may cause the trading price of our Common Stock to decrease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, we are not restricted from issuing additional
securities in the future, including our common stock, securities that are convertible into or exchangeable for, or that represent the
right to receive, our Common Stock or substantially similar securities. To the extent that we raise additional funds through the sale
of equity or convertible debt securities, the issuance of such securities will result in dilution to our stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may require additional financing to sustain
our operations, without which we may not be able to continue operations, and the terms of subsequent financings may adversely impact our
stockholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may receive an additional $3,750,000 gross
proceeds from the issuances of further Convertible Notes in the aggregate principal amount of $4,091,207 pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The extent we rely on the selling stockholder
as a source of funding will depend on a number of factors, including the prevailing market price of our Common Stock and the extent to
which we are able to secure financing from other sources. If obtaining sufficient financing from the selling stockholder were to prove
unavailable or prohibitively dilutive, we may need to secure another source of funding in order to satisfy our financing needs. Even if
we issue further Convertible Notes equal to $4,091,207 (for gross proceeds of $3,750,000) pursuant to the Purchase Agreement to the selling
stockholder, we may still need additional capital to finance our future working capital needs, and we may have to raise funds through
the issuance of equity or debt securities. Depending on the type and the terms of any financing we pursue, stockholders&rsquo; rights
and the value of their investment in our Common Stock could be reduced. A financing could involve one or more types of securities including
Common Stock, preferred stock, convertible debt or warrants to acquire Common Stock. These securities could be issued at or below the
then prevailing market price for our Common Stock. In addition, if we issue secured debt securities, the holders of the debt would have
a claim to our assets that would be prior to the rights of stockholders until the debt is paid. Interest on these debt securities would
increase costs and negatively impact operating results. If the issuance of new securities results in diminished rights to holders of our
Common Stock, the market price of our Common Stock could be negatively impacted.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Should the financing we require to sustain our
financing needs be unavailable or prohibitively expensive when we require it, the consequences could be a material adverse effect on our
business, operating results, financial condition and prospects.<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Management will have broad discretion as
to the use of the proceeds from our sale of Common Stock to the selling stockholder under the&nbsp;Purchase Agreement, and such uses may
not improve our financial condition or market value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to use the proceeds from
any issuance of Convertible Notes pursuant to the&nbsp;Purchase Agreement for general corporate purposes, including working capital.
Our management will have broad discretion in the application of such proceeds, including for any of the purposes described in <I>&ldquo;Use
of Proceeds,&rdquo; </I>and we could spend the proceeds from any issuances of further Convertible Notes pursuant to
the&nbsp;Purchase Agreement, if any, in ways our stockholders may not agree with or that do not yield a favorable return, or for
corporate purposes that may not improve our financial condition or advance our business objectives. You will not have the
opportunity, as part of your investment decision, to assess whether such proceeds are being used in a manner agreeable to you. You
will be relying on the judgment of our management concerning these uses and you will not have the opportunity, as part of your
investment decision, to assess whether the proceeds are being used appropriately. The failure of our management to apply these funds
effectively could result in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our
Common Stock to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The selling stockholder may choose to sell
the shares at prices below the current market price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder is not restricted as to
the prices at which it may sell or otherwise dispose of the shares covered by this prospectus. Sales or other dispositions of the shares
below the then-current market prices could adversely affect the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience future dilution as a
result of issuance of the shares, future equity offerings by us and other issuances of our Common Stock or other securities. In addition,
the issuance of the shares and future equity offerings and other issuances of our Common Stock or other securities may adversely affect
our Common Stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares sold by the selling stockholder will
be freely tradable without restriction or further registration under the&nbsp;Securities Act. As a result, a substantial number of shares
of our Common Stock may be sold in the public market following this offering. If there are significantly more shares of our Common Stock
offered for sale than buyers are willing to purchase, then the market price of our Common Stock may decline to a market price at which
buyers are willing to purchase the offered Common Stock and sellers remain willing to sell our Common Stock. The issuance of the shares
or any future sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales may
occur, could also adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares
of Common Stock or the availability of those shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in order to raise additional capital,
we may in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock
at prices that may not be the same as the price per share as prior issuances of Common Stock. We may not be able to sell shares or other
securities in any other offering at a price per share that is equal to or greater than the price per share previously paid by investors,
and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share
at which we sell additional shares of our common stock or securities convertible into Common Stock in future transactions may be higher
or lower than the prices per share previously paid. In addition, the exercise price of the Warrant may be greater than the price per share
previously paid by certain investors. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance
of shares of Common Stock under our stock incentive programs. In addition, the issuance of the shares and any future sales of a substantial
number of shares of our Common Stock in the public market, or the perception that such sales may occur, could adversely affect the price
of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability of those
shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All securities sold pursuant to this prospectus
will be offered and sold by the selling stockholder. We will not receive any proceeds from the resale of Common Stock offered by the selling
stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 29, 2025, the Company entered into the
Purchase Agreement with 3i, LP (the &ldquo;selling stockholder,&rdquo; or the &ldquo;Purchaser&rdquo;), pursuant to which the Company
issued to the Purchaser senior secured convertible notes, in the aggregate original principal amount of up to $10,909,885, which are being
issued with a 8.34% original issue discount (each, a &ldquo;Convertible Note&rdquo;), the first Convertible Note was issued in the original
principal amount of approximately $3,272,966, and the second Convertible Note was issued in the original principal amount of approximately
$ $3,545,712.42 (the &ldquo;Convertible Note Financing&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may receive up to $10 million in aggregate
gross proceeds from sales of the Convertible Notes to the selling stockholder pursuant to the Purchase Agreement, from time to time, if
the selling stockholder agrees to purchase and the Company agrees to issue and sell such Convertible Notes, subject to the conditions
set forth in the Purchase Agreement. We may use the proceeds from sales of our Convertible Notes to the selling stockholder for acquisition
costs and fees, and costs and fees associated with this sale of the Securities, with any remaining proceeds to be available for other
working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our expected use of proceeds from sales of the
Convertible Notes pursuant to the Purchase Agreement represents our intentions based on our present plans and business conditions, which
could change as our plans and business conditions evolve. The amounts and timing of our actual expenditures will depend on numerous factors,
including cash flows from operations, the extent and results of our research and development efforts, the anticipated growth of our business,
and other factors. We may find it necessary or advisable to use such proceeds for other purposes, and, except as set forth above, we will
have broad discretion in the application of such proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus, including the information incorporated
by reference into this prospectus, contains forward-looking statements. Forward-looking statements give our current expectations or forecasts
of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking
statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability,
our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. They are generally
identifiable by use of the words &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;projects,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;expects,&rdquo;
&ldquo;management believes,&rdquo; &ldquo;we believe,&rdquo; &ldquo;we intend&rdquo; or the negative of these words or other variations
on these words or comparable terminology. These statements may be found under the sections entitled &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Business,&rdquo; in our Annual Report, as well as in this
prospectus generally. In particular, these include statements relating to future actions, prospective products, market acceptance, future
performance or results of current and anticipated products, sales efforts, expenses, and the outcome of contingencies such as legal proceedings
and financial results. Such forward-looking statements include, without limitation, statements regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our need for, and our ability to raise, additional equity or debt financing on acceptable terms, if at all;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our need to take additional cost reduction measures, cease operations or sell our operating assets, if we are unable to obtain sufficient additional financing;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our belief that we have sufficient liquidity to finance normal operations;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the options we may pursue in light of our financial condition;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount of cash necessary to operate our business;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic conditions;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the anticipated future financial performance and business operations of our company; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain our core group of personnel.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in a very competitive and rapidly changing
environment. New risks emerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the impact
of all of those risks on our business or the extent to which any factor may cause actual results to differ materially from those contained
in any forward-looking statement. The forward-looking statements in this prospectus are based on assumptions management believes are reasonable.
However, due to the uncertainties associated with forward-looking statements, you should not place undue reliance on any forward-looking
statements. Further, forward-looking statements speak only as of the date they are made, and unless required by law, we expressly disclaim
any obligation or undertaking to publicly update any of them in light of new information, future events, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>DETERMINATION OF OFFERING PRICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder will offer shares of our
Common Stock for sale under this prospectus at prevailing market prices or privately negotiated prices. We cannot currently determine
the price or prices at which the shares of Common Stock may be sold by the selling stockholder under this prospectus. The offering price
of our Common Stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition
or any other established criteria of value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of shares of our Common Stock to
the selling stockholder pursuant to the conversions of the Convertible Note will have a dilutive impact on our stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our net tangible book value represents total tangible
assets less total liabilities divided by the number of shares of Common Stock outstanding on June 30, 2025. As of June 30, 2025, we had
a historical net tangible book value (deficit) of $(7,435,772), or $(1.38) per share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After giving effect to the issuance of 4,306,664 shares of our Common
Stock to the selling stockholder upon the assumed conversion of the convertible note, in the principal amount of $3,545,712 issued pursuant
to the Purchase Agreement, and after deducting estimated offering expenses payable by us, our as-adjusted net tangible book value (deficit)
as of June 30, 2025 would have been approximately $(7,435,772), or $(0.77) per share. This represents an immediate increase in net tangible
book value of $0.61 per share to existing stockholders and an immediate dilution of $1.52 per share to new investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates this per share
dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Net tangible book deficit value per share as of June 30, 2025 </TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(1.38</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &nbsp; &nbsp; &nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase in net tangible book deficit value per share attributable to the effects to this offering </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.61</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">As-adjusted net tangible book deficit value per share after giving effect to this offering </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.77</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dilution in net tangible book deficit value per share to new investors </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1.52</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The calculations above are based on 5,406,305
shares of our Common Stock outstanding as of June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>The
CONVERTIBLE NOTE Financing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 29, 2025, the Company entered into the
Purchase Agreement with 3i, LP (the &ldquo;selling stockholder,&rdquo; or the &ldquo;Purchaser&rdquo;), pursuant to which the Company
issued to the Purchaser Senior Secured Convertible Notes, in the aggregate original principal amount of up to $10,909,885, which are being
issued with a 8.34% original issue discount (each, a &ldquo;Convertible Note&rdquo;), the first Convertible Note was issued in the original
principal amount of approximately $3,272,966, and the second Convertible Note was issued in the original principal amount of approximately
$3,545,712.42 (the &ldquo;Convertible Note Financing&rdquo;). The shares issuable upon exercise of the first Convertible Note were registered
under a registration statement on Form S-1, File No. 333-289222, which was declared effective on August 11, 2025. The number of shares
registered for resale hereunder equals two hundred percent (200%) of the maximum number of shares issuable upon conversion of the second
Convertible Note&rsquo;s principal amount of $3,545,712.42 and accrued interest of $248,199.87, based on a fixed conversion price of $1.10
per share. The Company received gross proceeds of $3,250,000, prior to the deduction of transaction related expenses, from the initial
closing.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Convertible Note Financing
and the Purchase Agreement, on the same day, the Company entered into a Registration Rights Agreement and a Security Agreement with the
Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with certain applicable Nasdaq rules,
the Company may not issue to the Purchaser more than 1,093,195 shares of its Common Stock (the &ldquo;Exchange Cap&rdquo;) under the Purchase
Agreement, which number of shares is equal to 19.99% of the shares of the Company&rsquo;s Common Stock issued and outstanding immediately
prior to the execution of the Purchase Agreement, unless the Company obtains stockholder approval to issue shares of its Common Stock
in excess of such limit in accordance with applicable rules of Nasdaq. The stockholder approval was obtained on July 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, the Company may not issue or sell any
shares of Common Stock to the Purchaser, which, when aggregated with all other shares of common stock then beneficially owned by the Purchaser
and its affiliates (as calculated pursuant to Section 13(d) of the&nbsp; Exchange Act and Rule 13d-3 promulgated thereunder), would result
in the Purchaser beneficially owning more than 4.99% of the issued and outstanding shares of Common Stock, unless such limit is increased
by the Purchaser up to a maximum of 9.99%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides customary representations,
warranties, and covenants of the Company and the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Joseph Gunnar &amp; Co., LLC (the &ldquo;Placement
Agent&rdquo;) acted as the sole sales agent for the Convertible Note Financing. The Company agreed to pay the Placement Agent a cash fee
equal to seven percent (7%) of the gross proceeds upon each closing of a drawdown (each, a &ldquo;Closing&rdquo;) under the Convertible
Note Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>SELLING
STOCKHOLDER</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the possible resale
from time to time by the selling stockholder, 3i, LP, or 3i, of any or all of the shares of Common Stock that may be issued by us to 3i
under the Purchase Agreement. For additional information regarding the issuance of Common Stock covered by this prospectus, see the section
titled &ldquo;<I>The Convertible Note Financing</I>&rdquo; above. We are registering the shares of Common Stock pursuant to the provisions
of the Registration Rights Agreement we entered into with 3i on July&nbsp;29, 2025, in order to permit the selling stockholder to offer
the shares for resale from time to time. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights
Agreement, 3i has not had any material relationship with us within the past three years. As used in this prospectus, the term &ldquo;selling
stockholder&rdquo; means 3i, LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents information regarding
the selling stockholder and the shares of Common Stock that it may offer from time to time under this prospectus. This table is prepared
based on information supplied to us by the selling stockholder, and reflects holdings as of October 22, 2025. The number of shares in
the column &ldquo;Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus&rdquo; represents all of the shares
of Common Stock that the selling stockholder may offer under this prospectus. The selling stockholder may sell some, all or none of its
shares in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not know how long the selling stockholder
will hold the shares before selling them, and we are not currently aware of any existing agreements, arrangements or understandings between
the selling stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares
of our Common Stock offered by this prospectus by the selling stockholder.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership is determined in accordance
with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of Common Stock with respect to which the selling
stockholder has voting and investment power. The percentage of shares of Common Stock beneficially owned by the selling stockholder prior
to the offering shown in the table below is based on an aggregate of 7,906,205 shares of our Common Stock outstanding on October 22, 2025.
The fourth column assumes the sale of all of the shares offered by the selling stockholder pursuant to this prospectus.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares of<BR>
Common Stock <BR>
Owned Prior to Offering<SUP>(1)</SUP></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum&nbsp;Number <BR>
of Shares of<BR>
Common&nbsp;Stock&nbsp;to&nbsp;be <BR>
Offered Pursuant to</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number of<BR>
Shares of Common Stock<BR>
Owned After Offering</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Selling Stockholder</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>this Prospectus</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(2)</SUP></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3i, LP<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,781</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.237</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,306,664</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,781</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.801</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially owned prior to the offering all of the shares that the selling stockholder may be required to purchase under the Purchase Agreement, because the issuance of such shares is subject to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of control, including the registration statement that includes this prospectus becoming and remaining effective. Furthermore, the issuances of Common Stock are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any shares of our Common Stock to the selling stockholder to the extent such shares, when aggregated with all other shares of our Common Stock then beneficially owned by the selling stockholder, would cause the selling stockholder&rsquo;s beneficial ownership of our Common Stock to exceed the 4.99% Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or selling shares of our Common Stock under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so, or unless sales of Common Stock are made at a price equal to or greater than $1.00 per share, such that the Exchange Cap limitation would not apply under applicable Nasdaq rules. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under Nasdaq rules) may be amended or waived under the Purchase Agreement.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes the sale of all shares being offered pursuant to this prospectus, although the selling stockholder is under no obligation to sell any of such shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The business address of 3i, LP is 2 Wooster Street, 2nd Floor, New York, New York 10013. 3i&rsquo;s principal business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, and has sole voting control and investment discretion over securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC. We have been advised that none of Mr. Tarlow, 3i Management, LLC or 3i, LP is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, or an affiliate or associated person of a FINRA member or independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Mr. Tarlow as to beneficial ownership of the securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_009"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of Common Stock offered by this prospectus
are being offered by the selling stockholder, 3i, LP, or 3i. The shares may be sold or distributed from time to time by the selling stockholder
directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing
at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed.
The sale of the ordinary shares offered by this prospectus could be effected in one or more of the following methods:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
brokers&rsquo; transactions;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">transactions
involving cross or block trades;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
brokers, dealers, or underwriters who may act solely as agents;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;at
the market&rdquo; into an existing market for the ordinary shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through
agents;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
privately negotiated transactions; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
combination of the foregoing.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state&rsquo;s registration or qualification requirement is available and complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3i has informed us that it intends to use one
or more registered broker-dealers to effectuate all sales, if any, of our Common Stock that it has acquired and may in the future acquire
from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms then prevailing or at prices related to the
then current market price. Each such registered broker-dealer will be an underwriter within the meaning of Section&nbsp;2(a)(11) of the
Securities Act. 3i has informed us that each such broker-dealer will receive commissions from 3i that will not exceed customary brokerage
commissions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brokers, dealers, underwriters or agents participating
in the distribution of the shares of our Common Stock offered by this prospectus may receive compensation in the form of commissions,
discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the selling stockholder
through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of shares of our Common Stock
sold by the selling stockholder may be less than or in excess of customary commissions. Neither we nor the selling stockholder can presently
estimate the amount of compensation that any agent will receive from any purchasers of shares of our Common Stock sold by the selling
stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We know of no existing arrangements between the
selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares
of our Common Stock offered by this prospectus.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the selling stockholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the selling stockholder,
any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any other required information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay the expenses incident to the registration
under the Securities Act of the offer and sale of the shares of our Common Stock covered by this prospectus by the selling stockholder.
We also have agreed to reimburse 3i up to $25,000 for the fees and disbursements of its counsel in connection with the offering, payable
upon execution of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also have agreed to indemnify 3i and certain
other persons against certain liabilities in connection with the offering of shares of our Common Stock offered hereby, including liabilities
arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities.
3i has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to
us by 3i specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect
of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers,
and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed
in the Securities Act and is therefore, unenforceable.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The total expenses for the offering were approximately $308,116.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3i has represented to us that at no time prior
to the date of the Purchase Agreement has 3i or its agents, representatives or affiliates engaged in or effected, in any manner whatsoever,
directly or indirectly, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our Common Stock
or any hedging transaction, which establishes a net short position with respect to our Common Stock. 3i has agreed that during the term
of the Purchase Agreement, neither 3i, nor any of its agents, representatives or affiliates will enter into or effect, directly or indirectly,
any of the foregoing transactions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have advised the selling stockholder that it
is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the selling
stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or
purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the
entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security
in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This offering will terminate on the date that
all shares of our Common Stock offered by this prospectus have been sold by the selling stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is currently listed on The Nasdaq
Capital Market under the symbol &ldquo;CAPS.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_010"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain legal matters with respect to the securities
offered hereby will be passed upon by Lucosky Brookman LLP, Woodbridge, New Jersey.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_011"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements as of December&nbsp;31,
2024 and 2023, and for each of the&nbsp;years in the two-year period ended December&nbsp;31, 2024, incorporated by reference in this prospectus,
have been audited by GBQ Partners LLC, an independent registered public accounting firm. Such financial statements are incorporated by
reference in reliance upon the report of such firm given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those publicly available documents. The information incorporated by reference is considered to be part of this prospectus. Information
in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus. We
incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents
listed below &nbsp;that we filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Annual Report on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025026436/ea0235933-10k_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
10-K</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2024 filed with
the SEC on March 31, 2025;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Quarterly Reports on Form 10-Q for the period ended March 31, 2025 and June 30, 2025 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025044408/ea0242293-10q_capstone.htm">May
15, 2025</A> ad <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025077016/ea0252950-10q_capstone.htm">August 15, 2025</A>,
respectively;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Current Reports on
                                                                                                                                                                        Form 8-K filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025022822/ea0233925-8k_capstone.htm">March
                                                                                                                                                                        11, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025027128/ea0236535-8k_capstone.htm">April, 1,
                                                                                                                                                                        2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025058624/ea0247218-8k_capstone.htm">June 27, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025059265/ea0247484-8k_capstone.htm">June
                                                                                                                                                                        30, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025071366/ea0251365-8k_capstone.htm">August 4,
                                                                                                                                                                        2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025077073/ea0253483-8k_capstone.htm">August 15, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025077702/ea0253562-8k_capstone.htm">August
                                                                                                                                                                        18, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025096315/ea0259691-8k_capstone.htm">October 6,
                                                                                                                                                                        2025</A>, and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/887151/000121390025101673/ea0262225-8k_capstone.htm">October 23, 2025</A>; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
description of our Common Stock contained in our registration statement on </FONT><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025013797/ea023111101-8a12b_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
8-A12B</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">filed with the SEC on February 14, 2025.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the statements in the preceding paragraphs, no document, report or exhibit (or portion of any of the foregoing) or any other information
that we have &ldquo;furnished&rdquo; to the SEC pursuant to the Exchange Act shall be incorporated by reference into this prospectus.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference into this prospectus
all documents (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are
related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after
the date of the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the registration
statement, or (ii) after the date of this prospectus but prior to the termination of the offering. These documents include periodic reports,
such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as proxy statements on Schedule
14A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon request, we will provide, without charge,
to each person, including any beneficial owner, to whom a copy of this prospectus is delivered a copy of the documents incorporated by
reference into this prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference
as an exhibit in this prospectus, at no cost by writing or telephoning us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Capstone Holding Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5141 W. 122nd Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Alsip, IL 60803</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(708) 371-0660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus
to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_013"></A><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For further information with respect to our company
and the securities being offered hereby, reference is hereby made to the registration statement, including the exhibits thereto and the
financial statements, notes, and schedules filed as a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No person is authorized to give you any information
or make any representation other than those contained or incorporated by reference in this prospectus. Any such information or representation
must not be relied upon as having been authorized. Neither the delivery of this prospectus nor any sale made hereunder shall, under any
circumstances, create any implication that there has been no change in our affairs since the date of the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the informational requirements
of the Exchange Act, and must file reports, proxy statements and other information with the SEC, such as current, quarterly and annual
reports on Forms 8-K, 10-Q and 10-K, respectively. These filings are available on the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4,306,664 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Capstone Holding Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;13. Other Expenses of Issuance and
Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the costs and expenses,
other than underwriting discounts and commissions, to be paid by the Registrant in connection with the issuance and distribution of the
Common Stock being registered. All amounts other than the SEC registration fees are estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount to <BR> be Paid</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt">SEC Registration Fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Legal Fees and Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Accounting Fees and Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">55,616</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;14. Indemnification of Directors
and Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restated certificate of incorporation, as
amended, and the bylaws of the Company provide that the Company shall indemnify its officers, directors and certain others to the fullest
extent permitted by the Delaware General Corporation Law (&ldquo;DGCL&rdquo;). Section&nbsp;145 of the DGCL, provides in pertinent part
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a)&nbsp;and (b)&nbsp;of this Section, or in defense of any claim, issue or matter therein, he shall be indemnified against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by him in connection therewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any indemnification under subsections (a)&nbsp;and (b)&nbsp;of this Section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because he has met the applicable standard of conduct set forth in subsections (a)&nbsp;and (b)&nbsp;of this Section. Such determination shall be made with respect to a person who is a director or officer at the time of such determination (1)&nbsp;by a majority vote of directors who are not parties to such action, suit or proceeding, even though less than a quorum, (2)&nbsp;by a committee of such directors designated by majority vote of such directors, even though less than a quorum, (3)&nbsp;if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (4)&nbsp;by the stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses (including attorneys&rsquo; fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys&rsquo; fees) incurred by former directors and officers or other employees and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this Section shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A corporation shall have power to purchase and maintain insurance on behalf of any person, who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the corporation would have the power to indemnify him against such liability under this Section.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of this Section, references to &ldquo;the corporation&rdquo; shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this Section with respect to the resulting or surviving corporation as he would have with respect to such constituent corporation if its separate existence had continued.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of this Section, references to &ldquo;other enterprises&rdquo; shall include employee benefit plans; references to &ldquo;fines&rdquo; shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to &ldquo;serving at the request of the corporation&rdquo; shall include any service as a director, officer, employee or agent of the corporation, which imposes duties on, or involves services by, such director, officer, employee, or agent of the corporation, which imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &ldquo;not opposed to the best interests of the corporation&rdquo; as referred to in this Section.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indemnification and advancement of expenses provided by, or granted pursuant to, this Section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted by Section&nbsp;102(b)(7)&nbsp;of
the DGCL, the Company&rsquo;s restated certificate of incorporation, as amended, eliminates the personal liability of each of the Company&rsquo;s
directors to the Company and its stockholders for monetary damages for breaches of his or her fiduciary duties as a director except that
a director shall be liable to the extent provided by applicable law (i) for breach of the director&rsquo;s duty of loyalty to the Company
or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
(iii) pursuant to Section 174 of the Delaware General Corporation Law or (iv) for any transaction from which the director derived an improper
personal benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;15. Recent Sales of Unregistered
Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following sets forth information regarding
all unregistered securities sold by us in transactions that were exempt from the requirements of the Securities Act in the last three&nbsp;years.
Except where noted, all of the securities discussed in this Item&nbsp;15 were all issued in reliance on the exemption under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 25, 2025, the Company entered into
a subscription agreement with Nectarine Management LLC, an entity controlled by Michael Toporek, for the sale and issuance of 985,063
shares of Series B Preferred Stock for a total purchase price of $30,000. The shares of Series B Preferred Stock were issued on March
6, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 7, 2025, all of TotalStone&rsquo;s outstanding
Class B and Class C membership interests were exchanged for 3,782,641 shares of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 30, 2025, the Company entered into
an exchange agreement (the &ldquo;Exchange Agreement&rdquo;) with BP Peptides, LLC and Brookstone Partners Acquisition XXI Corporation
(together, the &ldquo;Brookstone entities&rdquo;), entities controlled by Matthew Lipman, the Chief Executive Officer of the Company and
Michael Toporek, the Chairman of the Board of Directors. Pursuant to the Exchange Agreement, the Brookstone entities exchanged notes with
an aggregate principal and interest amount of approximately $1.94 million for 642,276 and 825,067 shares, respectively, of the Company&rsquo;s
newly created Series Z 8% Non-Convertible Preferred Stock. The exchange was based on the closing price of the of the Common Stock on Nasdaq
of $1.32 per share on the day prior to the transaction.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;16. Exhibits and Financial Statement
Schedules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(a) EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed herewith, or, as noted, incorporated
by reference herein, the exhibits listed on the accompanying Exhibit Index of this registration statement and below in this Item&nbsp;16:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated by <BR>
Reference</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed or<BR>
Furnished</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 57%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 6%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 6%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 9%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing Date</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Herewith &nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex3-1_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated Certificate of Incorporation, dated April&nbsp;22, 2005, as amended on May&nbsp;21, 2010, June&nbsp;22, 2015, August&nbsp;22, 2019, February&nbsp;10, 2021, and February&nbsp;18, 2022</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184315003566/exh_42.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws of the Company</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/23/2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex3-3_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Certificate of Designation of Series&nbsp;A Preferred Stock, dated June&nbsp;22, 2015</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex3-4_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Certificate of Amendment to the Restated Certificate of Incorporation</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex3-5_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Certificate of Designation of Series B Preferred Stock</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025096315/ea025969101ex3-1_capstone.htm">Certificate
of Designation of Preferences, Rights and Limitations of Series Z 8% Non-Convertible Preferred Stock</A>&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/6/2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex4-2_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Warrant to Purchase Common Stock, dated March&nbsp;20, 2020, issued to BP Peptides, LLC</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184318000822/exh_102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant to Purchase Common Stock, dated January&nbsp;30, 2018, issued to BP Peptides, LLC</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2018</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026208201ex5-1_capstone.htm">Opinion of Lucosky Brookman LLP</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-1_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184316011964/exh_101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&nbsp;B Preferred Stock and Warrant Purchase Agreement, dated August&nbsp;25, 2016, by and between LipimetiX Development, Inc. and Capstone Therapeutics Corp.</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/26/2016</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317004105/exh_101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase, Loan and Security Agreement dated July&nbsp;14, 2017, by and between Capstone Therapeutics Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/17/2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184318000822/exh_101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to Securities Purchase Loan and Security Agreement dated January&nbsp;30, 2018, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2018</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated by <BR>
Reference</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed or <BR>
Furnished</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing Date</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Herewith</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 57%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184319001827/exh_101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;15, 2019, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/19/2019</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-6_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;27, 2020, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-7_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;15, 2021, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-8_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination of Securities Purchase, Loan and Security Agreement, dated November&nbsp;13, 2024, by and between Capstone Holding Corp. and BP Peptides, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317004105/exh_102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note dated July&nbsp;14, 2017, payable to BP Peptide, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/17/2017</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-10_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March&nbsp;27, 2020 and Effective as of November&nbsp;26, 2021</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-11_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent and First Amendment to the Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March&nbsp;27, 2020 and Effective as of November&nbsp;26, 2021</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-12_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Credit Agreement, dated March&nbsp;8, 2023, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Stream Finance, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-13_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent, Waiver and Amendment to Second Amended and Restated Credit Agreement, dated October&nbsp;18, 2024, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Stream Finance, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-14_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-negotiable Secured Subordinated Promissory Note by and between TotalStone, LLC and Northeast Masonry Distributors, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-15_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-negotiable Secured Subordinated Contingent Value Promissory Note by and between NEM Purchaser, LLC and Northeast Masonry Distributors, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-16_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookstone Partners IAC, Inc. Amended and Restated Management Fee Agreement Dated March&nbsp;1, 2020 by and between TotalStone, LLC and Brookstone Partners IAC, Inc.</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-17_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Fee Agreement, dated March&nbsp;27, 2020, by and between TotalStone, LLC and Capstone Holding Corp.</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-18_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment of Amended and Restated Management Fee and Transaction Fee Agreement, dated November&nbsp;15, 2024, by and between Capstone Holding Corp., TotalStone, LLC, and Brookstone Partners IAC, Inc.</FONT></A></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-19_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limited Payment Guarantee dated March&nbsp;31, 2021, between Capstone Therapeutics Corp. and Brookstone Acquisition Partners&nbsp;XXI Corporation</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&nbsp;B-2 Preferred Stock Purchase Agreement, dated August&nbsp;11, 2017, by and between Capstone Therapeutics Corp. and LipimetiX Development, Inc.</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to the Amended and Restated Stockholders Agreement of LipimetiX Development, Inc., dated August&nbsp;11, 2017</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_103.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joinder of August&nbsp;25, 2016 Registration Rights Agreement of LipimetiX Development, Inc., dated August&nbsp;11, 2017</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-23_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LipimetiX Development, Inc. Contingent Value Rights Agreement, dated August&nbsp;23, 2019, by and among Capstone Therapeutics Corp., the Shareholder Representative and Computershare Inc., and Computershare Trust Company, N.A., as Rights Agent</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated by <BR>
Reference</B></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed or<BR>
Furnished</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing Date</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Herewith</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 57%"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-24_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Promissory Note, dated November&nbsp;11, 2024, issued by Capstone Holding Corp. to BP Peptides, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-25_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revolving Credit, Term Loan and Security Agreement by and among TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Berkshire Bank, dated December 20, 2017</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-26_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments to Revolving Credit, Term Loan and Security Agreement Still in Effect As of December 30, 2024</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-27_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Revolving Credit Note Issued by TotalStone, LLC and Northeast Masonry Distributors, LLC to Berkshire Bank, dated November 14, 2019</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-28_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term Note Issued by TotalStone, LLC, Northeast Masonry Distributors, LLC, and TotalStone Properties, LLC to Berkshire Bank, dated November 22, 2021</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-29_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, dated November 11, 2024</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-30_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Master Exchange Agreement by and among Capstone Holding Corp., TotalStone, LLC, and TotalStone&rsquo;s Class B Member</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-31_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Subscription Agreement for Purchase of Series B Preferred Stock</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-32_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Employment Agreement by and between Capstone Holding Corp. and Matthew Lipman</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex1-1_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriting Agreement</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025052677/ea024508401ex10-34_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Purchase Agreement, dated May 14, 2025, by and between Capstone Holding Corp. and Tumim Stone Capital, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/9/2025&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025052677/ea024508401ex10-35_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement, dated May 14, 2025, by and between Capstone Holding Corp. and Tumim Stone Capital, LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/9/2025&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025071366/ea025136501ex10-1_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated July 29, 2025, by and between Capstone Holding Corp. and 3i, LP</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025071366/ea025136501ex10-2_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Secured Convertible Note, dated July 29, 2025, issued by Capstone Holding Corp. to 3i, LP</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025071366/ea025136501ex10-3_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement, dated July 29, 2025, by and between Capstone Holding Corp. and 3i, LP</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025071366/ea025136501ex10-4_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Agreement, dated July 29, 2025, by and between Capstone Holding Corp. and 3i, LP</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/4/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40&dagger;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025077702/ea025356201ex2-1_capstone.htm">Membership Interest Purchase Agreement, by and between Capstone Holding Corp., D22L, Inc., David Clary, and Stuart Powell</A></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/18/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025096315/ea025969101ex10-1_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agreement by and among Capstone Holding Corp., BP Peptides, LLC, and Brookstone Partners Acquisition XXI Corporation, dated September 30, 2025</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">10.42</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025101673/ea026222501ex4-1_capstone.htm">Senior Secured Convertible Note, dated October 22, 2025, by and between Capstone Holding Corp. and 3i, LP</A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">8-K</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">4.1</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">10/23/2025</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex21-1_capst.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea026208201ex23-1_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of GBQ Partners LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="padding-left: 10pt; text-align: center; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026208201ex5-1_capstone.htm">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</A></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&#8239;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&#8239;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&#8239;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">X</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea026208201ex-fee_capstone.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules and exhibits to this agreement have been omitted. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(b)&nbsp;Financial statement schedules.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All schedules have been omitted because either
they are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;17. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To file, during any period in which offers, or sales are being made, a post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any prospectus required by Section&nbsp;10(a)(3)&nbsp;of the Securities Act&nbsp;of&nbsp;1933;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule&nbsp;424(b)&nbsp;if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That for the purpose of determining any liability under the Securities Act&nbsp;of&nbsp;1933 each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That, for the purpose of determining liability under the Securities Act&nbsp;of&nbsp;1933 to any purchaser, each prospectus filed pursuant to Rule&nbsp;424(b)&nbsp;as part of a registration statement relating to an offering, other than registration statements relying on Rule&nbsp;430B or other than prospectuses filed in reliance on Rule&nbsp;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That, for the purpose of determining liability of the registrant under the Securities Act&nbsp;of&nbsp;1933 to any purchaser in the initial distribution of the securities:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&nbsp;424;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned Registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described in Item&nbsp;14 above, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned Registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the Registrant pursuant to Rule&nbsp;424(b)(1)&nbsp;or (4), or 497(h)&nbsp;under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Alsip, Illinois, on October 23, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capstone Holding Corp.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 37%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Matthew E. Lipman</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Matthew E. Lipman</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew E. Lipman</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Edward C. Schultz</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward C.&nbsp;Schultz</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Michael M. Toporek</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael M. Toporek, III</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Charles Dana</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Dana</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ John M. Holliman</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John M.&nbsp;Holliman, III</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Gordon Strout</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gordon Strout</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Fredric J. Feldman</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fredric J. Feldman</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Elwood D. Howse</I></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 23, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elwood D. Howse</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">II-8</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P> </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea026208201ex5-1_capstone.htm
<DESCRIPTION>OPINION OF LUCOSKY BROOKMAN LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><B>LUCOSKY BROOKMAN LLP<BR>
</B>101 Wood Avenue South<BR>
5th Floor<BR>
Woodbridge, NJ 08830<BR>
T - (732) 395-4400<BR>
F- (732) 395-4401<BR>
__________________</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">111 Broadway<BR>
    Suite 807</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">New York, NY 10006<BR>
    T - (212) 417-8160<BR>
    F - (212) 417-8161</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">___________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">www.lucbro.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">October 23, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capstone Holding Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5141 W. 122nd Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alsip, IL 60803</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><B>Re:</B></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><B>Registration Statement on Form S-1</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to you, Capstone Holding
Corp., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with filing with the U.S. Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) of a Registration Statement on Form S-1 (as amended or supplemented, the &ldquo;<U>Registration
Statement</U>&rdquo;) pursuant to the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;). The Registration Statement
relates to the resale by certain selling stockholder of up to 4,306,664 shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s
common stock, $0.0005 par value per share (the &ldquo;Common Stock&rdquo;), consisting of 4,306,664 shares issuable upon conversion of
the convertible note, in the principal amount of $3,545,712.42 issued pursuant to certain securities purchase agreement. All capitalized
terms used herein and not otherwise defined shall have the respective meanings given to them in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering of the Shares will be as set forth
in the prospectus (the &ldquo;<U>Prospectus</U>&rdquo;) contained in the Registration Statement, as amended, and as supplemented from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In rendering these opinions, we have examined
the Company&rsquo;s certificate of incorporation and bylaws, both as amended and currently in effect, the Registration Statement, and
the exhibits thereto, and such other records, instruments and documents as we have deemed advisable in order to render these opinions.
In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of
all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photo static copies and the authenticity of the originals of such latter documents. In providing these opinions, we have further relied
as to certain matters on information obtained from officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are opining herein as to the Delaware General
Corporation Law, and we express no opinion with respect to any other laws. This opinion is limited to the laws in effect as of the date
the Registration Statement is declared effective by the Commission and is provided exclusively in connection with the offering contemplated
by the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the foregoing and the other matters
set forth herein, it is our opinion that, as of the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in">1.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">The Shares have been duly authorized by the Company, and when issued and delivered by the Company upon the conversion of the Convertible Note in accordance with the terms thereof, will be validly issued, fully paid and non-assessable shares of Common Stock.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is for your benefit in connection
with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions
of the Securities Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our
firm in the Prospectus under the heading &ldquo;Legal Matters.&rdquo; In giving such consent, we do not thereby admit that we are in the
category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Very Truly Yours,</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><I>/s/ Lucosky Brookman LLP</I></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Lucosky Brookman LLP</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea026208201ex23-1_capstone.htm
<DESCRIPTION>CONSENT OF GBQ PARTNERS LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="height: 77px; width: 400px"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B><IMG SRC="ex23-1_002.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2025 related to the consolidated financial
statements of Capstone Holding Corp. appearing in the Annual Report on Form 10-K for the year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the reference to us under the
caption &ldquo;Experts&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ GBQ Partners LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Columbus, Ohio</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 23, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea026208201ex-fee_capstone.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.3a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: d9a4922b9b79ea1442cff850b5d12d16 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-1</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000887151</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_004"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000887151</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-23</xbrli:startDate>
          <xbrli:endDate>2025-10-23</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000887151</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-23</xbrli:startDate>
          <xbrli:endDate>2025-10-23</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-1</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">Capstone Holding Corp.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_009">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_010">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_011">Common stock, par value $0.0005 per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_012">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">4,306,664</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">1.0350</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">4,457,397.24</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">615.57</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_018">4,457,397.24</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_019">615.57</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_020">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_021">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_022">615.57</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_023">Pursuant to Rule 416 under the Securities Act of 1933, as amended, the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.<br/><br/>Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, as amended, based on the average of the high and low prices of the Company&#8217;s Common Stock reported on the Nasdaq Capital Market on October 20, 2025, a date within five business days prior to the initial filing of the registration statement to which this exhibit is attached.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %" CL# 2(  A$! Q$!_\0
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MKO4M'^ +?M,O\4]6^+9^&X\70^'6^#KHK>%F^$LGBH>+E%J+78ZM#]K>#_\
M@EU^PW\._ NO?#_PW\"_^*1\3^(O@]XGU?1==^)?QC\:2-J'[..MIXS^!6CZ
M3K/BCXB^)/$GA[PS\*?$.EP7'A+P?X6FM?!]LRR0CPC/#(R5T_Q*_P""<7[&
MGQ6T[XFV?CWX)Z;K/_"X?C%X>^/_ (XUI/%WCG0/$[?''0?!^A>!M%^)G@[Q
MGH/BBR\0_#OQ+%X8\/:#X8AN_AA<>$I6ACD90\D\N\ _'+QS_P %E/'&D?$3
MX*?&[Q?X5\1?#WP9\"/@I_P6-LOVR?V;O"_B'1?&FG>*OCM_P3\U?X"^'XM+
M\$>./^$88:[X=77_ !'K[>"/%4:>#HF7Q'(_CJ)4\+M'7.^*O^"MG[8'[//Q
MW^/OCW]I+X4>';#3=!_8K_8L\4_##]FCX7_%B3XD>"KSXF?M6?M->)?A9X.\
M:ZQXY7X:>%O%&A;7UO0O"WCV,^$?%:V\/@)YO $GBY_$T2G]N="_X)R?L2^$
MO#OPX\%^'_V<O!D?AKX5?#_XW_"?P1X=O;C7M3TNP^'_ .TE'H,?QXTG6X];
MURZ'C<_%3_A'-&_X3+Q%XM_X2KQ1<RJ";SS+FY+>4>%O^"17_!//P%X0^)/@
MO0?V:K"]\/\ Q6^'_AOX8^.K'Q-X^^+7C'4-;\#> ]>_X33X?:&GB+Q)\1_$
MGB+19_AIXCCCG^'VO^%Y[;QAX(DTCPZG@Z^MX?"UAL /BZP_X*Z?M*>*K3X
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M;?M&2K!\5_!?@S1=9^(<_A[X?^&/%IN!OT+P;;>%8K*,3'P>+1HW63L?$O\
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MBCQAXU'[)/[/?_"6?$.[\>7'C+Q(GPG\&OJOBF3XKZ/KOA[XK/KTLN@DR_\
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M,]0\1ZM\._ 6J>*FTO\ X2?4O"/AF]\1#2V9M+_MB;2(I-7_ +(P2P47#2!
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M,T?\(EX8_P"A9T+_ ,$VF?\ QF@#:^V6G_/U;?\ @4G_ ,51]LM/^?JV_P#
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M VOMEI_S]6W_ (%)_P#%4?;+3_GZMO\ P*3_ .*K%_X1+PQ_T+.A?^";3/\
MXS1_PB7AC_H6="_\$VF?_&: -K[9:?\ /U;?^!2?_%4?;+3_ )^K;_P*3_XJ
ML7_A$O#'_0LZ%_X)M,_^,T?\(EX8_P"A9T+_ ,$VF?\ QF@#:^V6G_/U;?\
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M,T?\(EX8_P"A9T+_ ,$VF?\ QF@#:^V6G_/U;?\ @4G_ ,51]LM/^?JV_P#
MI/\ XJL7_A$O#'_0LZ%_X)M,_P#C-'_")>&/^A9T+_P3:9_\9H VOMEI_P _
M5M_X%)_\51]LM/\ GZMO_ I/_BJQ?^$2\,?]"SH7_@FTS_XS1_PB7AC_ *%G
M0O\ P3:9_P#&: -K[9:?\_5M_P"!2?\ Q5'VRT_Y^K;_ ,"D_P#BJQ?^$2\,
M?]"SH7_@FTS_ .,T?\(EX8_Z%G0O_!-IG_QF@#=\^#_GK#^8_P#BJL5YEX@T
M'0]/E\/W%CH^G6$Y\6Z3FYM+./3L9+9.8U7=NZ<94[>G6O3: "BBB@ HHHH
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M>!SX'5X%\9_\)K&T8^TY?CY\?_AM^PO\.OVKOB5KG@[Q?K.DZ+\,_CC\?O\
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MBO6232^;1_-5X5^(O[4W@W5/%OC;XB:W^U3:>/?BM\-OV.=$\1:J/!NL>&_
MV@:5X$UO]IG0/&_C/6]<\/?!/XMCX>CQ6NA^"1XW_P"$2\&^,?&G_"9>/O#
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M6Y1*/]BU)1X95:-&/-Q1Q!0HX7(>':,E:,N'\B]AB<_DI)R3E)2IQYE?]MO
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MEM?#7B_4+2.31\&=7EBT*2+<@/S&)G#,IV2OA6-C_A>7PZ_Z"VL_^$=XR_\
MF;^O^1RGP0&?AQI'_86\5C\_&6OBO6_('J?\_A]?\GC5\JW_ %9JWAE]F_\
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M/C?/_4M?^HAH%;4$JZ=U:W3\M=3IP6'PV(YD[JRO>^^MNI^QU%%%8G$%%%%
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M**** "BBB@ KB]9_Y&'P1_U]:M_Z9GKM*XO6?^1A\$?]?6K?^F9Z .THHHH
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MG^,/A?=^*_$>D?$?POH7QA\$+XA^*W[*7@K7?!)7'PA\/^+/V4]"_P"%9^.
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M&/C)K>O:X-5^&@T'0/AKX3/AKP_%H 5D\/?%;QEXM^,,!T 7%P?)\3;H^/\
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M!$GBQE\6>/?"V8(F5U'U'X8_X*F^,/B#^UGX]\.>"OBS^SE!\,]&\5>&M'^
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M44 %%%% '%>+O]7X>_[''P]_Z'792?<;Z5QOB[_5^'O^QQ\/?^AUV4GW&^E
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M#E?M/C/_ *!GAG_P=:Q_\SE'VGQG_P! SPS_ .#K6/\ YG*ZJB@#E?M/C/\
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MPM@!Z $@YYX[]/3TH U:Y.6?Q@9)Q!I?ALQ<?9OM6LZL&SCG>%\.G'/92?\
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M'O\ L<?#W_H==E)]QOI0-;KU7YH\C^!__).],_["OBO_ -3'7*A^-OQ:\._
MOX6>/_B]XRBOKK0O 7AZ_P#$5S9Z%:_;=5U1K9FCTG1M'M]A>76?$4LL.BVX
M4[3=3QXE@0JYF^!__).],_["OBO_ -3'7*Z?QYX#\(_$_P '>)_A[X]T6P\1
M>"?&6D:AX=\2>'M319-.UK3-60)/;S+GY@ZE@ ,,)&++RJ$F)U<K:^FO1]KF
MF(:^M2N^K_-'P%XL_;J\9^$-0UKPKXG_ &4OB=;^.O WPX\3?&CXB^%+/QQ\
M,-6L-%^!_APZ:!XPTC7#XC6/QWKNOS/J?A^#PK:BWNH[OPMXH,T[%_"(\9\]
M-_P4C75?%G]@_"W]F_XE_%/2=4\8>)OA_P""/%MMXN^&WAG2/%OCCP3\&-(^
M.NL0HFN>(X]=\/\ AU/ARY5_$_BJ'YO&8'@N:(32I(/6K[_@GG^S)JL-Q_;F
M@_$G7-6U6TU+1?&/C35/CE\8[_QM\1_"NN1:3HFN_#?XG>-Q\1F\4_$#P#<Z
M!H.A^'7\&^*KBY\*16^APE[6-WD9O8M,_9;^!VD:K::[HW@:#3]0TOQYXD^)
M=FUMJ.M#3K;QUXQ^&0^$VNZT='77!&([GX?D^&7T18E@6W<?9X8W<3J&1\M>
M!?\ @I!X.\=W?AG6K'X1?$RP^$7B?QE\,?AK8_%G6+_PDFWXG?%GX/>&_B_X
M*T%O!47B8>)F\.2Z'XRT7PTWB=E:$>,)'A%N]H&\4MPGAS_@JMX7\<:Q<>"_
M"WP6\4>(?B#<^)OACH'A+PQX4^)OPT\3:?KC?%.P^*ESH<6M>--'\03>%_#^
MN^&C\*_$ \;^'5F\5S6")&FG#Q22'A]2^%__  37_9\\ >*_&NNW]CKGBSPI
MKGB?2=8\&?#?5/%_C!OAIX#TOP]\!/!'P#T>&/P*OB.?PUXD\4CP)X?UR)_B
M;XLCD\9;=?9(Y5D*.OHW@;]@O]F;X<:QX8\6:3X0\57WB;P,/ UGX/USQE\3
M_B3XRU#P_I/PIC\?Z3\+?#VF/K_BBZ1?#O@^/XH>-T\(^'@/LZ_\)!( "^T(
M ?+6J_\ !57X=>'X/".LZKX=\2:7<_$?PQX#MO"7PU\3GPAX8&B>.M7\=?'K
MP9XTTC7?B>_B67PF-&\+/\$O&B7DP ^U_P!@>')O Q\7MXNBAB[GX=?\%,OA
MQ\3OB5\$_ FA?#3QKX9MOC#86&J:9JOQ#U?P;\.C/JKZMX\T#6]'\#:/KWB6
M)OBW-X/\1^!]8A\9-X4,R-8:YX=\6^!H_&:2AHO=[W]A7]G"YLHXM/\  NK>
M'[_2FT^'P[XG\+>/_B+X;\8^%&TKQGX]\=IKG@_QIH?B,>*-#UN'7_BM\2YL
M074+S6WB&Y\%M&/!HBM)+,?[$W[/,.N> -9_X1SQ??7'P[NO VM:3I6I?$SX
MG:IX:OO%/@/6I-?\$^-?'.@ZUXI;0?'?C[PUXCU.X\16WBSQ7%<^,1*499KC
M*PN!==T?9U?CK^U%_P EU\<_]RS_ .H?X?K]BJ_'7]J+_DNOCG_N6?\ U#_#
M]=>7_%+_  /_ -*1W8'XY_X5^9^Q5%%%<APA1110 4444 %%%% !1110!R,O
M_(]V/_8IZM_Z=]#KKJY&7_D>['_L4]6_].^AUUU !1110 4444 %%%% !17A
MO[0FKR:%\"OC'K4/CF[^%DVC_"WQY>6?Q*TOPUJWC34/AM,GA#6/+\=+X+T@
M"Y\3-X0('B)?#L8*7#:4,L6*-'^!_@K]K3QU^S59>)-'\'7J_$_QGXH\-_LY
MVLGC'PI^UKK'[8W[+=ZWQ2^-\'PJUGX^ZQK7QBU[PI\2_@]\09CK#-)\-/%7
MC7P5\'/%WE1&V\;^=X4\87-J ?TQ45_.=J7_  4+_:1TGQIHOB2[TO1;S6/$
MVE>&?@REGI&L^#]?^#^A:B?VF/C%X 'Q\GT&+XW)X5TC7?%'AOP=I/A>/PE-
M^T:T:^-3'X+/C5KB-9S] >#/V_?C=XT'A"WUKQ#^S!\#+C3O 8\9:U>?$N]U
M7Q/IOQGU)/V@OB#\#!HGPM/@;XE8T(/X?\#Z+XFSX4_X7*__  FWQ#\+^!R5
M53)XO /VQHK^;7X?_P#!1C]J7P=\,/@GH5]>_#WXN^*+3X"+\8/'/Q#\4S>#
M?!$?Q+U'6_V@O'GPJ3X:Q:KK_P </"EOX \1^$- \#^7XW\4^&8/C"S^,]<\
M.1/X$\(VS!9/J3X"?M6_%GXU_M<? .WUOQU\/M$\.>,OAQ^W9?W7[.7A1=6T
MWXE?#:;X3?&;X0_#WP_)\<D_X2GQ,OB+Q)'&NLH47PGX'_X0[Q;KOB.UCD\7
MHJ", _::BOYLO&'Q>^.?@;XN_M#R77Q2UK6+_P >?M'_ !D\.>&]5TCQ)\2_
M#9^&O@3X(?%']BC1=$\':+H3?$CQ=\-"[^'_ (J:^[O)X.\'-)(WBEF+/XO?
M'TSX;_:B^)FE?L2^%]9U;P?\6/&7B*6?PQJ-U\;-2UQ+#P/JZZY^U8OP^/@V
M?QIH?Q"_X6=#XF7P[-M#0>$3X1,45N&N?(EDM  ?MI17X./_ ,%!?VKK+PMX
M=\4W$'[.E\WQA\ >./&'P]TJ2TU3P6?!+> /VF_AY\"-;TF;6_'_ ,9_"'A;
MQ[XE\6^&_&S>*?!7A/Q+XN^"T3>--(E\$'QGEXVC_3+]D'XS7/[0?P$\'_%#
M4KVSO]7U6Z\6Z5XDO]+\(ZSX*TN7Q/X+\;:_X(\0+;Z#K7B+Q8]J$DT&.(O9
M^,/&/A20K+-X+\:>,?!DEGJ$H!]8T444 %%%% !1110 5Q>L_P#(P^"/^OK5
MO_3,]=I7%ZS_ ,C#X(_Z^M6_],ST =I1110 4444 %%%% !17Q5^W?J5]H_[
M+WQ&N=-^,5M\!;^>?P7HUA\5]7O?&.F^'= EUSQSX=T8Z1X@\:> W_X2GX?>
M'?%0G/A3Q/\ $Y5Q\/[;Q _C=YV_X1U(XOR;\"?MF?$CX*)+\'/AQI^J3ZSK
M7QZ'@K6?$?B_XY:'^V%^SY\*PG[/NO?%8:/\&/C;\0/B-^SIXD\0R>+9=!$W
M_"LOBC\6[;QCX,=?$AB2.'Q?X-1@#^CFBOYW]&_X*#_M)P7UCK4.E:%IVM_'
MWQU\'K';JFJ^#OB)\-O@PY_8R\/_ !:UG2? YUKXW_"#PIKW_"U?$7F-X+3_
M (6V0T__  D4T9\5M"JGU#PM^WK\?/BWX2\3ZH?&7[./P&\06W@KPUI6B_"G
M6AJ7Q&^)GC;Q/X[_ &?C\5X_B5\)];\,_$2'POK_ (9BU[6A;^!3_P (=XS\
M(^-8O /B59?'7A,M(Y /W0HK^>#X5_\ !13XP?#'X7:-XV\9-X4^,=AJO@3]
MGGP WBW2;SQDNI>+/VBOBS^RAX!\?? W.AQ^(_%?A7P]H'Q4^([:W\,?&<GA
M0"9?&NO>&7#LS2L_T9\*?VZ?V@?$O[5,'P6\5>"?A[;>']*^/'BK]G7Q)IEI
M<Z-X=\6+J/@?X.2?$+6/C%H"Z]\9AXI\0>&O$/B.0QVW@\?!MF7P1KGA;QHW
MC>1BXD /V3HK\+?C7^V?\3_@GXG_ &E?#WAGQKX<NO%!_:(^+R>$-+^(/AR?
MQEI]CX#^%'[)G[,WC_7-&T;_ (2+XE?"+PYH&@1>)?'/F>,'E\8>?;R>())/
M '@KQ?(S%K/@;]OO]HOXD^'_  E\0!?_ +/?PB^'GQ(^*WP=^#=GXN\8>'?&
M'B/3OA/J?CK]D[P+^TMK'B_QSKR_$7PAX7U^W\2>(M>'P&\"^%=GA%QXSU[P
MS++XYFN9)?",P!^Y-%?SO_#G_@JE^T;XUO/!-Q9^"_@IK5C;6GP>;Q)=>'[_
M $CP[X8^,[?%C]H/Q[\*)=;^%&M?$/XW>$_$OAO0/#7A_P $M+X0=/!_QA?Q
MUXX9O!<Q\(2-OKZ)_;)_:=^*W[/7[4'BN[\(?%7X8:+X>\(_L8GXO)\(OB6=
M<U%_BYXGT+XRZUH__"'?"_1M"\4>%&T/X@>*=##^$8?%&[QFA\5:[X1@/@>6
M(,S@'[+T5_.1\1/^"C'[4OCOX7_M)W'A_2?"'P?DM/@]^VMK'A2^NU\'#XE?
M W5OV:]:_L30-<US0I?C=+XJ^("^*)B9/&"O\(_A"_@8Z]X9V2^,MS%OM3X$
M?MH_$;Q=^UO?? #Q]X@^$FH>%=1_X3K1OAWJOPUT5/$L/CT^!](\-:Z?$$OC
MGP_\:/&$OP^\201ZQKP\9_##XK_"+P5&$;PW_P (1XZ\8*$D\6 'ZQT444 %
M%%% !1110!Q7B[_5^'O^QQ\/?^AUV4GW&^E<;XN_U?A[_L<?#W_H==E)]QOI
M0-;KU7YH\?\ @F/^+=:7[ZOXH _#QEKV>?Q'Y5)\9/B18_";X4_$;XDW<,5Q
M;_#_ ,$>*/&+VT[?+=+X<T277"HZ,H8P;&*G<&.5(ZU)\%<#X<Z2?35?%?\
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MQY'\7:+I?@[0].T[Q2WELK?VWI$6AK!K>$9@#<K(<,P4X8BO4:_EJ_X.'O\
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M^$4B\')7] /_  5"_P""H/Q!^&'_  3F_9N\:_LP6MUIW[8__!2>R^!?@/\
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M3S4C*[95$:LOFGQ5_9_\)_%;P6? -W>:UX!TMM?L?$%I<?#.XTSP[J,6I:+
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M]'\:^)_&^L>,/ _]BB/PV_B&636M$2TGD\7>#P$M5+,R$[_ZI*_E4_X*Y_\
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M(^"AKFNCP^==CUO1/$%Q%KOASPKK^N:5:^._"WBSPA!XUAT]H?%]K=2!+?\
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MM'_^:"@#LJ*XW_A*KK_H4_%7_@-H_P#\T%'_  E5U_T*?BK_ ,!M'_\ F@H
M[*BN-_X2JZ_Z%/Q5_P" VC__ #04?\)5=?\ 0I^*O_ ;1_\ YH* .RHKC?\
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M ,!M'_\ F@H [*BN-_X2JZ_Z%/Q5_P" VC__ #04?\)5=?\ 0I^*O_ ;1_\
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M_91\(^./#G[*OQAC?RWDT+_A5!^*GCB:!99)9Y3H/PT4.5\)((^^_P""8O\
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M?0_BSKJ^,O!'B'Q$/A?X%F5="3P__P )#X2\(^,)I?%,L?Q!MU\*+X6@\%3
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MSP9JA\ >!OC=\*?%'Q^^!"^(/ SD>*]2\=?$]G^!7P3\;Z%H'P5^+OB?7?$
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M7PWX6\):UKJK&FHZAX7\&:QXFUC0-&G"N28?#]QXX\130_(")=:?<^"BCN:
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MHN/[?\3:+X?\/^"$U:<F1F\]/#F@Z+X?X6,K!H\:LA(9W]&H **** "BBB@
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MJ_\ IUFI2V_KS ]6HHHK Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUC5_#OAR#0(DU[PU:(?$<OB#QOX)\WP[*S.D'B+P_P")QOMIVE3R/Q'^P?\
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M%7@?Q%K'VO5?%_@3XEZ5XG\4V/A'?8>.?A5K'@77? ['1? GAGP7X<.A13>
M]!4P^2KI'OR))2JQ>>ZE_P $Y?@GJLUE/J/BCXF75SX7@T:R^&PN]6\(Z_I7
MPGTG1[CX@?\ $E\$:)KOPWN?#W]C)9_%/QAX96#QA;^*Q+X6>"W#I_PCL8A
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MH:38ZK=+X5TCPUXQ3Q3J;Z)H_A[7)9VT75M"1O#V@/'XR\/B'Q;XD^R^"_\
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M;\+^#O'=[X?^-7QET_4?'/A?0T^ ^6$H!\2#Q#L\#>.U+J_@Y?\ BH-NX?\
M"9>,MUBY_86_:Q\*Z;XN\.^$OB6FK?#[Q#\;?B7\2]$\%P_$7QAX+U/1O GB
M'QO\==8\!_!D:]!X<DC'ASPM<>/_  +\<T\5GR_&4WC7P[XK\&>-1XVM%\%S
MMVGCK]JO]K#P0NKZ _\ 8&N^(]/^(NH^ O'&H0_L_?$O3/#/PH\!:-J^O+H/
MQKUCQ!'XC\7>&=?3XLQ+X>">&8I /!R^(.1M\'^,<]Q\)_VI?VA_%/Q=C\$?
M$SPSI_@31-2^'G@'Q+/<>&OAC\1_$VF^%M4UAOA7_;NC:\WB?_A$_$V@S^)[
MSQ%KWA_P9,GA7Q3X6:>/?)<2OX,\:6\P :+^RK\:_!/P%\7?#F!M*\0:UJ?[
M1NG?%3QI;+\7/&6EG]H+PSK.B>'CXZTG6_'9\.CQ'X"UKQ)XCWI.T44Z^*I-
M!+3O#%XIN"GS7\4/V7OVZK+5=9\;Z?<G4M)NCX8\+:Q\.OAK^T#\9[[5O%GA
M<?$_X"C0=%/C7Q(J^*A_PBOAO0/';>-/%)4>9'KWB>1"T?B_QBU>@_%CQ1\3
M4_:S^/=AX8\<_M(?\+>T+XH_LQC]G+X9Z#=?$H?!'6_ACK?A#X?'XI?VYHW]
MA2? W^P-P^*K^-?%?BGS/&7@YU$RS1,O@A)>)UO]NK]M6P\(^)M4A^%UE'XM
M1-5N]&TN'X7?$O51X2\5:'HOC[77^ 7C=0%1?$K#1/! 7_A$5\7^,/%R>(I4
MMHX$N/":R@&[?_L0_M91WVH>,+;6/"?BC6!K/CQ/A;H'B#XZ_&4_\*'\"^.O
M!FMZ /!>C:ZB[=>/A42)X;4D*&B;SD'DY88^E?L0?MN>#[T^,K'Q!\/_ !IK
M&D^$?B;X6TCPIXK^,'Q)T[3K_3==\:_%OQ#\)]!US6M!\-,3X>^%:>.=" 0+
MO9=#&S#%2-1_VM_VQ/!FB>,-4L_AEK7BCQ,?$/BGQE\./A1XN\!^,9+[XT?V
MW\2_'T.N^"M%^)[O_P (O\']!^ 'A;2-&\1M)XJC8O"&BE?841L6S_;9_:1U
MSX@W^E:-J.F>*? GA/Q!J_@GQ5\==.^!GQDTSPW\/-,USP-^R+X]7Q9X@^"\
MOB*67Q#X@\,>(_BAXU\+^#6)9GV;I1(OA#QLK@%#QY^PI^UCXZT?1_"=C<6&
MC^"],\(:IX-O/#7BK]I;XG^--7\>>%-<^%_Q:T37](\<>-7\-!F\0^)OC)XA
M\/>*)6\(^#_!_@S_ (0YEB1//\*QP'IO&/[$W[;^O>'/$VEZ'\1[?PWXF\06
M7C__ (0+QO9_M ?$[3C\&?#&M^-/BYX@_P"%8IH@\-?\5"/%OAKQOX)\,+\4
M0#XU\(#0 T9(\'^#-WV=\4OB1XL\;?LL?%/5M)^(?B/PSXULM)\"IJ?B/P)\
M&/B5IGB/X;2^(-&^'?B'67U;P'_PD<GQ+?0AH.O-XB\8#PQ)%X[\#^"]>F%M
M&WC?PHS-^:O@[2_VQ?C[X_M_#'P\\4?%OPEX.T#X+>.U\'_$W7?VBOV@= ^&
MVG>/W^-!.A?$WP.NM?#3PKXJ_: \/>%?#LAQ\+OVA%P3HG_""_\ "<^,_ C_
M /":L ??GBW]D3QRWP7^(OPQLQ8>--(M_P!J+X??&+X1>$_$7Q2^(@:P\"^'
M]:^%'B#6_"=QXYUN+Q7XH\/>=XDT'QYXE7:/%T"RZ^RQQ!I/E^:;/_@G?^T1
MH'@OP?X!\$?%R\\$>'_#'P9TG3=%_LOXO_&%1H?[1FC? '6_ *>.(M&9EBE\
M+GXBS^'_ !2OAE'?P83H2^,3X&:\)@._\._BS\3/"/[2/Q(TOQ-\0OBOJ6BV
MG_"W[[Q#XM\4:7\7M.\._"O3&U[06\$+XW^"?BC01\-&T$)&?#GP8\7?L_>,
MEE\:HYE\;^#&N1XT9.?_ &HO'G[0F@?MUW=OX*U3XHR^'["S_8^N_"G@;POK
MWQY4:_IFM?%#Q];_ !R'@SP%X=T&3X%>)1)X7301XU\5_%=WC\'PHI)C5DCH
M V-._8[_ &NX-:^&6I1?$34="\+:;XBU"XM?!I^-&LZB?A-_Q<WP-XB'B_1]
M;_X1OS?'J^)O#.B>(/#4GA:9$BA'B-]SJ?%LW_"%>Q_&']C;XJ?$KXE?&'QW
M_P )SKUL?$OB7QM>^!+:T^,GQD\-Z;H_AD_LS?#_ ,"_#+1X_#_AUX_#.AGP
MG^T5H^M?%!VBC*I<3#QG&;F[W6J?++_MH?MM>(?&PT_PU\)[BYT\64>L>&_$
ME[\*_B;86&AZKXTU@>'M8\&^//!NA>)3X=\22>$%'_"3CPT_C-O''<L6R:]_
M^/WCW]K+5O@O\&-<\+77C?3/BC\//VU?'-KXRB^'_AS4_#>E_%;X8_ W1_C[
MK2:1KVB?\5=+_P *_P#B]X<\$Z'"IWM&?&>L^%T0*02X!SFD_L8?M/:QXS\/
MVOCSQ_>MX+@\<Z7J'QHN]+^./Q3%[^T-II\:>(=;&KOI"Q>$4^'C>$?#^L:+
MX8F\)>%7_P"$0\7#<SJJ^$/!5>8Z-_P3H_:&FNK[Q'XBU[P[_P +:TWX#:I9
MZ+\5;/XT?%#^V-1_:+USX-?L_?#_ $7QMK<13S2O@[Q-\%M8\33>+"FWQ8WB
M$B;P1&4<+X-\4OCO^VGHKZOXX@A_:??2=0_:8O?V@=%\"Z!X8\5CQ/K7P;U?
MX+_LU:WX>_9.^%.A>&_"RLOQ'8:]K_B4>%OBN1X&7QI'\3QXVC\79E_X1#[P
M^&_QG_:.UO\ :YMOB)J?@;XG6O[)GQ6UC6/@=X/_ +4N5;P]X7U3P]X-'B/0
M_BC-X"7PV?%NAOXK^)6E?$[X;3^+?$K0^$)/"<GPNE5XFG52 <YJOP&_:V\
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M'/QTUO4O 2Z[\9=98F)O#X\7:!H/C;PXH!NKGP>WQ D\<1(WC4$V^#_PQO\
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M T+38-(T?3-*MK2"PM]-TVQL[:S@F-V+()&(A&K,B[U3"J)>0X5B#M%;]%%
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LH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O ,(# 2(  A$! Q$!_\0
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MQ476_P#UA[?I7?+_ #'I6#X3\.6WA7P_:Z7;(H\M!YC <LW<^]=!28PHHHH
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%E% S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !T EL# 2(  A$! Q$!_\0
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M)YQ4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%4M2MKVZAA6QOOL;K,CN_E!]Z _,F#TSZTT)NR+M%%%(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115">UOY-
M9M+F+4?*L8T836GD@^:2.#NZKC^E-(3=B_1112&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !5>_GEM=.N;B&$SRQ1.Z1#J[ $A?
MQZ58J*ZN8K.TFNIVVPPHTCM@G"@9)P/84UN)["6<TMQ8V\TT#02R1J[PL<F-
MB,E2?;I4U16UQ%=VL-S VZ&9!(C8(RI&0<'D<5+0]P6P4444AA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5FZSJ%WIUO!):6#WK
MR7"1,B'!53U;\*TJJ:AJ=II<44MY*8TEE6%"%+99N@X%5'?:Y,G9;V+=%%%2
M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(X"JW*%9K=F' D0AES[9&#[$T12;283;46X[B_VS8^7>.)MRV;[)MJDD-Z
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MB+4[+3=3M8K:%XG::2*<RXVARSMN7&<@L< =>.1UHY(.7_!\_P"M!>TJJ/\
MP/+:U^_4W)+J"&U-U+*D< 4,9'.T >^:JVVM6=Q%-(?.MTA7>YN86A^7GYAN
M R.*J7EI>:CHZVT BB9$@F@ED.Y6D5@VUE'('RCG/?IQS-=+J5_931+;16T@
M17C:63>#*"&P0!]W(Z]?:H4(VU-74G?1=.V_^7ZDMEK-I?3>5$)T<@L@G@>+
M>OJNX#/;IZU73Q1I<@1UEE\F10T<WD/L<D9VJV.6_P!D<YXZC%*(+R_U*QN+
MJU6V6TW2<2ARTC*4P./N@,3G@DXXIVFZ?):Z1H]LZ('M402@=-PC(./7YC3:
MIK_A_4E2K/1??;TZ7]?N+5AJ5OJ22&#S5:)MLD<L31NIQGE6 /0U;J%8F%[+
M*<;6C11]06S_ #%35E*U]#IC>WO;A1114E!1110 4444 %,FFCMX))Y6VQQJ
M7=L9P ,FGT$@ DG % ,9#-'<01S1-NCD4.K8QD$9!I]'49%% #/-C\WRO,3S
M,9V;AG'KBGUR]U80:>[WE[HMO=J+@RF]AP9D!<L&;(!^7@<,>!T XK;M;IWN
M-2$S 1V\X12>,+Y4;')^K&M90LKHPA5;=I*S_K^M"WO7>4W#>!G;GG'K3JYO
M4I9;G1]0.Y$E;2@YD\L$\AR1]./PS5.VO+_3?#FD6[7C/)=HNR:*S,C0QB,'
M:J+G<?<\>H[52HMK1_U:YF\2HRLUI:_XV.PJ-IX58AI4!'4%A6=H5U<W%M*E
MTT\K1/A9YK5H#(I&?ND#D<C@8XJAK^F:3<SPV1TZV:]U!\&40+O5!R[EL9''
M /JPJ537/RR+E5?L^>*^_P#KN="\T4:!Y)45&X#,P -/KF+2QM+[Q#JEE>6T
M4UO8QP1VEO+&"D:%,DJ#QR1C/^SBD2W@>"+2VF:;3_[1> *SY!01,PCSZ*_R
MX_V<53I+:_\ 3)5>6]NZWZK3[OZZG2QRQS)OB=74_P 2G(I]84%K!IOB>*WL
M(HX()[222:&) J[E9 K8'0X9A[X]JW:SG%+8VIR<D[[K0****@T"BBB@ HHH
MH **** "BBB@ HHHH *@NKRWLD1[B38KN(U.TG+'H.*GI"P7&2!DX&:!.]M!
M:**IZNLC:/>"&7RI/);#[<XX]*:5W84G9-DUM=VU[&9+6XBG0,5+1.& /ID=
MZFKDHQ>V&D65A;7K&\N!YJ+9V4881A0,89@@ )'S-UZ"I;/7+V?0%U.3<'LY
MWBN8?* :<*=O"D_*_0@9ZY'<8W=![Q>ARQQ2VDM;7_S^Y.YU%%4=)N);W3X[
MR5A_I'[Q$&/W:GHN>Y'?WS5ZL&K.QU1DI)274*;YL8E$1=?,(W!,\X]<4ZN+
MTU4ET6VUN^T:SGF=UFEGW?O@V[[PRO&#C W=!^%:0AS)LRJU>1I+UZ[+T.R+
MJ'"%@&8$A<\G%*S*N-S 9.!D]36%=6\,?C339TB599;>X\QP.6QY0&3[?U/K
M6=>7L=[>:7J$\\<:_;$$,!E&43:^6<9X8\=>@P."351I7M;M_G_D1+$<M[K5
M.WY:_B=?3!+&TC1B13(HR5!Y'X4\C(Q7.V]AIZZU#'IEBBM;.7N;T $DD,/+
M+G+.Q)!.<X'4YQ6<8IWN:U)N+5NIOF6-9%C:11(W*J3R?H*1IX58AI4!'4%A
M7.ZSIMC-<FVM+?.KW+AQ=A/,>VP<[RQY4<8"Y&>@XSA^OZ587,L5M'I=D][?
M.0\[P*62,<NY.,YQ@#W85HJ<7:[W_K[C*5::YK):>OW>OX:G1@Y&135EC=V1
M75F3[P!R5^M4-9D:TT"\>W#*T<#;/+X*\=1Z8JE:6%MI>HVFW1K&U:7="DUL
M^6SM+8;Y!D$*>23S41@G&YI*HU)1MZ[^AN"2,R&,.I<#)7/('TI&EC1T1Y%5
MGX4$X+?2N12R-E%9;M#\F_BN(1+J.8_WA,@5F# ESO!/!'\7-2:A8;)]3DN]
M%-X\I+PWNZ,B)-O RQ#)M.3\H/J.:T]C&^_Y?Y_\$P^L2M?E_/M?M\NWF=5+
M-% F^61(UZ;G8 4^N12WN+F/3[[4]+?5HY;"%?+(0F&4CYR4<A?FW#GJ-O85
M>\(374NG7BW"%(X;Z:*W4G(6('A0>X!RH/M[4I4K1;OL7#$<TU%JU_\ )/7I
MUZ'04445@=04444 %5I+^VBOH;)Y<7$P+1IM/S =>>E6:3< P7(R>@S0)WZ"
MT444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M.>%+BWD@D&8Y%*,,XR",&I*9,KO#(D<GENRD*^,[3C@X[T,3"&%+>".&(;8X
MU"*,YP ,"GTR)72%%DD\QPH#/C&X]SCM3Z$-&1_PC6F[QA)Q '$@MEN'$(8'
M</W>=N,\XQCVJ:XT.RNKU[J59=T@"RHLS*DH'0.H.&'L>HX-5KC6;]IG73-'
MDO(8G9'F:=8@6!P0@.2V#D<X&1UJ\^IVD%E%=7DJV228P+IA&03_  G)Z_X5
MNW55G<Y4J#NK:>EE]^P\6-L$9#&"K0B JQR"@SQ^IJFOA[3UTY+';.T,3B2(
MM.Y:(@8&QLY7 X ']35BYU%(&T_RU65+R81*ZOP 49PP]?N_K5DW$*Q-*9HQ
M&I*ERPP"#@C/UX^M1>:-.6E)M-+3_AR.RLHK&$QQ-*^YMS/+(SLQP!R2<] /
MRIXMHA=FZV?OC&(]Q[*"3@>G)_' ]*BGU/3[:413WUM%(S;0DDJJ2>#C!/7D
M?F*6WU"RNYI(;:\MYI8N)$CE#,G;D \4FI;E)T](IHAOM(MK^9)I#-%,BE!)
M!,T3%3SM)4C(S2-HFG-I*:6+95LX\;(T)7:0<@@@YSGG.<TS3==L=1AM<7-N
MEW/"DIM1,K.NY0V,=> ?2K[3PHDKM+&J19\QBP 3 R<^G'-4W4C[KOH1%4II
MR5G?^OZ_$KV.F0:>9&C::223 >2>9I&(&<#+$\#)X]S5RJDVIZ?;O$D]];1/
M* 8U>95+@],9/-6ZB7,]9&D.5+ECT"BLF]U>X2Z>TTRP-_<18\\>:(DBR,@%
MB#DD=AGWQQEC:^(]'O;R6T>*YLHR\UH[C<IQD<C((/8U7LI:$.O!-IO;]-]3
M9HJO>W0LX%E*;MTL<6,X^^ZIG\-V:L5%M+FMU>P456OKV.PM_-=9)&)VI'&N
MYY&QG:!Z\'V&"3@"J5UJE^EC:W5EI8NEFC\R0&Y6,1# (Y8<]3^54H-D2J1C
M>_0UJ*Q;+6[JZT4W[:5*)'?;!!%()/-'&&W< +UY/89YR,K;ZS=R17,<FDR#
M4(-I-K',C JV=K!S@8^4@]QCH>,OV4M?+T)5>#MY^3_R_ V:*PIM?NV33A8Z
M7]JFO+8W)C^T*GEK\G<CGEQ6M92W$]I')=6WV:9L[HO,#[>?4<'CFE*$HJ['
M"K&;M'\G^?S)Z***@U"J]Y8V]_&D=PA=4<2  D<CITJQ4-S'/*B""X\A@X+'
M8&W+W'/KZTGL)JZU)J9+&LT3Q.,HZE6'L:?13&4+G2+6Z%ODS1M;J4C>&9D8
M*<9&0>0<#\J9;:#I]H(5AB8+#,TZ*9&(WL""QR>>IQGI6E15\\K6N9^RA>]M
M?Z_R1#;VL5J)1$"!)(TA!8D!CR<>F3S]23WJ:BBI;ON6DDK(*RV\/V#W7G.)
MV'F^<(3._E"3.[=LSC.>>G7FM2BFI..S)E",OB5R"2TAEO(+MU)FA5T1L] V
M,\?\!%+<6L-TT)E4DPR"5.<88 C/ZFIJ*5V/E78KM9Q-=/<'>)'B$)(<@;<D
M\#L>3SUK/L?#5CIWE+:R7L<<1RD0O)-@YS]W=C&>U;%%4IR2LF2Z4&[M:F,O
MABPCEFDBEOHFFD,LGE7LJ!F/4D!JTA:1"]:\P?.,8BSN. H)/3IU/6IZ*'.3
MW81I0C\**RV,"FZ^4L+DYE#,2#QMZ=A@=JK6>A65E<I<1_:))(T*1F>X>01J
M<9"AB<=!^5:5%+GEM<;IP;3ML9</A^QANHIP;ES"VZ&.6X=TC.",JI.!P3].
MU%QX?L+FYEFD^T#SF#31I<.L<A  ^90<'@ >^.:U**?M)WO<GV-.UN5&?>Z-
M:7URMRYGBG5/+\V"=XF*YSM.TC(S5R""*UMXX(4"11J$11V Z5)12<FU9LI0
MBFY):L****DL**** "JTEA;RW\-ZZ$SP@JC9/&>#Q5FJ\D-PUY%*ESL@4$/#
ML!WGL<]1BDQ-%BBBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "F3,Z0R-''YDBJ2J9QN/89[4^B@!D3.\*-)'Y;E063.=I[C/
M>GT44 8$&I'1A+8W-A?OY;,\4L$#3+,K,2!D9PW8AL>O0TDLDUKK46J7UE.8
MI+98D$2F9K5\DL"J@_>&T;AGE<'MGH**U]HM[;[G/[%VMS;;:+^G_74Y.RL+
MJ)=/?[-)%"^K/<QP8)-O$T4F-P_ARQSCL7QUI;N><Z9>:9'I]XUQ]J=L^2WE
ME&F+A@V,'@@8'.>V 2.KHJO;7=VB/JR4;)_U8Y[4-.6?3_$V;/S)+@'9F/)D
MVP)MQZX;./0Y[TC6DT6N>'GA@D6..VEBF94("C:FU6/;D< ]Q7144E5=K?UM
M8IX>+=_ZWN<3:J9?#FE:0NCW:7T?DMN>!E6!AAC*9", XSP#G)VXJ_JUQ-%;
MZ]8)87LTUTC- 8H2R.#"%^]T!!4\'D\8R2!73T53K7=[>>_G<A86T;<W2VRV
MM;^F<CJ#75NEM]EM+J2[-O!&UN]IYD%P 3A2W_+,J6)R2 /0UTMO>QW-S=P(
MKAK:01N2."2H;C\&'XU9I%4*,* !DG@=S42FI*UC6%)PE=/0P8Y)-!U&^\^V
MN)K6]G-PDUO$TI1MJJ595!(^[D'I]*I7MO=:AH^O:@+2>)KVT6*&V>/][A W
M) SR2YXZ\5UE%-5;.]M=/PM_D1+#W7+?37\;_P";,._T:**&&2!KZ21+JW;:
MUY-(,"5,DJS$' R>1QC/:MRBBLY3<DDS:-.,6W'J8UU8ZHVK/>0RVSQA0L,<
MV_$?'S$ <$DYY/;CCG-<22P>'K2UU33Y;B"6$13?9D9C&N  &4?-ZYQG&*Z&
MBK539-;$.@KMI[_,YJ#4KO3-*FF6QO[F%[GR[.(Q,TB1[1RXP6"Y#=03@BK7
MA]U?SWD6[>]DPT\\]FT&_KM501T Z#\>];=%$JB::MN*-%QDGS72\OZ_X"T.
M846]K8:/]NTV_=ULEC\V"-V\OY5)1E3YAR!VZCM6QHQD;2HFECGC+%V5+@DR
M*I8E0V><A<=:OT42J<RM8=.CR.]_P]/\@HHHK(W"H;F2>)$,%OYS%P&&\+A>
MYY]/2IJ*35T 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *@DEN%O(HDMM\# EYO, V'L-O4YJ>BDU< HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !8 +0# 2(  A$! Q$!_\0
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MO9K#1KJ[;R+C3M"T*\U1H[";572_OT9B]CX:\2212V]K^'G_  ;W?\% WD^
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$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 23, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000887151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Capstone Holding Corp.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Oct. 23, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common stock, par value $0.0005 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">4,306,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1.0350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 4,457,397.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 615.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 416 under the Securities Act of 1933, as amended, the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.<br/><br/>Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, as amended, based on the average of the high and low prices of the Company&#8217;s Common Stock reported on the Nasdaq Capital Market on October 20, 2025, a date within five business days prior to the initial filing of the registration statement to which this exhibit is attached.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 23, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 4,457,397.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">615.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 615.57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea026208201ex-fee_capstone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea026208201ex-fee_capstone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea026208201ex-fee_capstone.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea026208201ex-fee_capstone.htm">ea026208201ex-fee_capstone.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="21">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea026208201ex-fee_capstone.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea026208201ex-fee_capstone.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 21,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026208201ex-fee_capstone.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-101720-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-101720-xbrl.zip
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M_875V8[%>6[LE?),"K0KWA<2&P.%S>!ZZ0[ <M27"DI>\AMPCV[4] (_OXW
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E965?8V%P<W1O;F4N:'1M4$L%!@     !  $ 3    # +      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea026208201ex-fee_capstone_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000887151</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-23</startDate>
            <endDate>2025-10-23</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000887151</identifier>
        </entity>
        <period>
            <startDate>2025-10-23</startDate>
            <endDate>2025-10-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-1</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000887151</dei:EntityCentralIndexKey>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_004" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_005">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_006">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">Capstone Holding Corp.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_009">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_010">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_011">Common stock, par value $0.0005 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_012">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_013"
      unitRef="shares">4306664</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">1.0350</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">4457397.24</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="USD">615.57</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">4457397.24</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">615.57</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_020"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_021"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_022"
      unitRef="USD">615.57</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_023">Pursuant to Rule 416 under the Securities Act of 1933, as amended, the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.&lt;br/&gt;&lt;br/&gt;Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, as amended, based on the average of the high and low prices of the Company&#x2019;s Common Stock reported on the Nasdaq Capital Market on October 20, 2025, a date within five business days prior to the initial filing of the registration statement to which this exhibit is attached.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
